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Abstract
Tight junctions (TJ) constitute the primary component of epithelial barrier function, a disruption of which
is involved in the pathogenesis of many gastrointestinal, pulmonary and renal diseases. Occludin is the
major transmembrane protein of TJ, a deletion of which leads to a complex phenotype including chronic
inflammation in several epithelial tissues of occludin deficient mice and poor TJ integrity in epithelial cell
lines. Its down regulation was seen in Crohn’s disease, tumors of the colon, brain, endometrium and
breast cancer. Occludin is also known to be a target that enables Hepatitis C Virus infection and bacterial
pathogenesis. But the specific function of occludin in TJ remains unknown. Numerous studies implicated
that occludin phosphorylation plays a crucial role in TJ regulation. Based on our previous studies, we have
identified a conserved phosphorylation hotspot in the C-terminal domain of occludin, called occludin
regulatory motif (ORM), which has a potential to confer dynamic properties to occludin. The present study
was designed to determine the function of ORM in TJ regulation. Stable, occludin-deficient MDCK cell line
(OD-MDCK) that expresses wild type occludin (OclWT) or a deletion mutant occludin (OclDM) that lacked
ORM were developed. Confocal imaging and immunoprecipitation analyses showed that absence of ORM
does not prevent occludin localization and interaction with ZO-1 at TJ. However, FRAP analysis showed
that mobile fraction of occludin is reduced by the absence of ORM, suggesting the role of ORM in
occludin dynamics. Also, Ca2+ depletion-induced disruption of TJ, adherens junctions and cytoskeleton
and barrier dysfunction were attenuated in the absence of ORM. Mutation anlaysis of ORM phosphosites
Y 398, Y 402, T403 and T404, revealed that ORM-mediated phosphorylation events determine the dynamic
properties of TJ. Then the role of ORM-mediated protein interactions in TJ modulation was investigated. A
synthetic peptide analogous to occludin regulatory region (ORP), which enhanced TJ assembly and
attenuated radiation-induced barrier dysfunction in Caco-2 cells, was used as bait to pull down proteins
that interact with ORM. Proteomic analyses and pull down assays using ORP and GST tagged occludin Cterminus identified that MAP7 (an epithelial specific microtubule associated protein) interacts with ORM
in a tyrosine phosphorylation-dependent mechanism. Furthermore, MAP7 binding to occludin in Caco-2
cells was elevated by treatment with osmotic stress or dextran sodium sulfate, both known to increase
occludin Tyr-phosphorylation. These data demonstrated that MAP7 interacts with ORM and mediates
occludin redistribution during TJ disruption. In conclusion ORM confers dynamic properties to TJ via its
phosphorylation dependent protein-protein interactions. The findings in my project establish the
functional significance of ORM in TJ dynamics and regulatory mechanisms associated with TJ
modulation. Identification of proteins that interact with ORM provides new therapeutic targets in the
treatment of diseases associated with occludin depletion and epithelial barrier dysfunction.
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ABSTRACT
Tight junctions (TJ) constitute the primary component of epithelial barrier
function, a disruption of which is involved in the pathogenesis of many gastrointestinal,
pulmonary and renal diseases. Occludin is the major transmembrane protein of TJ, a
deletion of which leads to a complex phenotype including chronic inflammation in
several epithelial tissues of occludin deficient mice and poor TJ integrity in epithelial cell
lines. Its down regulation was seen in Crohn’s disease, tumors of the colon, brain,
endometrium and breast cancer. Occludin is also known to be a target that enables
Hepatitis C Virus infection and bacterial pathogenesis. But the specific function of
occludin in TJ remains unknown. Numerous studies implicated that occludin
phosphorylation plays a crucial role in TJ regulation. Based on our previous studies, we
have identified a conserved phosphorylation hotspot in the C-terminal domain of
occludin, called occludin regulatory motif (ORM), which has a potential to confer
dynamic properties to occludin. The present study was designed to determine the function
of ORM in TJ regulation.
Stable, occludin-deficient MDCK cell line (OD-MDCK) that expresses wild type
occludin (OclWT) or a deletion mutant occludin (OclDM) that lacked ORM were
developed. Confocal imaging and immunoprecipitation analyses showed that absence of
ORM does not prevent occludin localization and interaction with ZO-1 at TJ. However,
FRAP analysis showed that mobile fraction of occludin is reduced by the absence of
ORM, suggesting the role of ORM in occludin dynamics. Also, Ca2+ depletion-induced
disruption of TJ, adherens junctions and cytoskeleton and barrier dysfunction were
attenuated in the absence of ORM. Mutation anlaysis of ORM phosphosites Y 398, Y
402, T403 and T404, revealed that ORM-mediated phosphorylation events determine the
dynamic properties of TJ. Then the role of ORM-mediated protein interactions in TJ
modulation was investigated. A synthetic peptide analogous to occludin regulatory region
(ORP), which enhanced TJ assembly and attenuated radiation-induced barrier
dysfunction in Caco-2 cells, was used as bait to pull down proteins that interact with
ORM. Proteomic analyses and pull down assays using ORP and GST tagged occludin Cterminus identified that MAP7 (an epithelial specific microtubule associated protein)
interacts with ORM in a tyrosine phosphorylation-dependent mechanism. Furthermore,
MAP7 binding to occludin in Caco-2 cells was elevated by treatment with osmotic stress
or dextran sodium sulfate, both known to increase occludin Tyr-phosphorylation. These
data demonstrated that MAP7 interacts with ORM and mediates occludin redistribution
during TJ disruption.
In conclusion, ORM confers dynamic properties to TJ via its phosphorylation
dependent protein-protein interactions. The findings in my project establish the functional
significance of ORM in TJ dynamics and regulatory mechanisms associated with TJ
modulation. Identification of proteins that interact with ORM provides new therapeutic
targets in the treatment of diseases associated with occludin depletion and epithelial
barrier dysfunction.
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CHAPTER 1.

INTRODUCTION

Epithelial Tight Junctions
Luminal and vascular fluid spaces are delimited by epithelial and endothelial
barriers. The characteristic property of forming a barrier between external and internal
milieu that generates and maintains physiological functioning of compartments is mainly
attributed to the intercellular junctions. These include tight junctions (TJ; also Zonula
occludens), adherens junctions (Zonula adhaerens), desmosomes (macula adhaerens) and
gap junctions (Figure 1-1A).
Tight junctions (TJ), originally identified by Farquhar and Palade in the early
1960s, are the most apical sites of cell-cell contact (1). On a freeze-fracture micrograph,
TJ appear as a belt-like ring of continuous anastomosing strands sealing and eliminating
the intercellular space (Figure 1-1B) (2). This led to the early belief that TJ form an inert
and impervious barrier, which later was disproved as TJ components have now been
identified to be under continuous remodeling at steady state (3). TJ do not seal the
paracellular space completely but regulate the paracellular transport of solutes based on
charge and size. Modulation of barrier properties of TJ in response to physiological,
pharmacological and pathological stimuli has been demonstrated in several studies (4-9).
Physiological Functions of TJ
Epithelial TJ serve two main functions: a “gate function” where the TJ strands
from neighboring plasma membranes associate with each other and provide selective
permeability to ions, water and solutes through paracellular diffusion and a “fence
function” that prevents intramembrane diffusion of proteins and thus confers polarity to
cells (10,11). Besides their role in these classical functions, several studies reported that
TJ play an important role in signal transduction (12-14).
Early Discovery of TJ Components
The first component of TJ was discovered in 1986 in mammalian epithelial and
endothelial cells and named as Zonula occludens-1 (ZO-1; 225 kDa) (15). The next TJ
associated protein called Cingulin (160kD) was discovered in in 1988, in avian brushborder cells (16). Both of these are not integral membrane proteins and the search for
membrane associated TJ components continued. Occludin (65 kD) was the first integral
membrane protein of the TJ to be discovered by Furuse et al in 1993 (17). Occludin is a
tetra spanning membrane component of the TJ strands, which interacts with ZO-1 and
confers adhesive properties to cells (18,19). Then another class of transmembrane
proteins with no sequence similarity and phylogenetically unrelated to occludin called
claudins (21-34 kD) were discovered in 1988 (20). Claudin family of proteins includes
nearly 27 members, mutations of which cause hereditary diseases (21).
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Figure 1-1.

Intercellular Apical Junctional Complex and Tight Junctions.

A. Schematic shows intercellular junctions between intestinal epithelial cells. B. Electron
micrograph of mouse intestinal epithelial cells shows intercellular junctions. Inset shows
freeze fracture micrograph of tight junctions as continuous anastamosing strands present
at the apical end. Scale bar is 200nm. (Mv, microvilli; TJ, tight junction; AJ, adherens
junction; DS, Desmosome; Ap, apical membrane; Bl, basolateral membrane).
Source: Reprinted by permission from Macmillan Publishers Ltd: Tsukita, S., Furuse, M.,
and Itoh, M. (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2,
285-293. Copyright © 2001.
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Characteristics of TJ
Electrical Resistance
The two-membrane model suggested that apical and basal membranes differ in
their conductance properties. Sodium passes across the apical membrane via the Na
channels into the cells down its concentration gradient, while it is pumped across the
basolateral membrane via energy dependent Na,K-ATPase. The shunt pathway suggested
that this electrical gradient generated by the active transport of Na+ leads to passive
diffusion of Cl- ions through the paracellular route. This revealed that the transcellular
and paracellular transport are physiologically coupled.
Transporters in the apical and basolateral membranes mediate transcellular
transport. According to the electrical circuit model, the series elements of the resistance
of apical (Rapical) and basolateral (Rbasolateral) membranes are in parallel to the resistance of
the TJ (RTJ). Because the resistance of cell membranes (Rapical and Rbasolateral) is usually
high, it is the resistance of TJ (RTJ) that determines the transepithelial electrical resistance
(TER). It is well accepted that the resistance differs significantly among various tissues
and hence referred to as either “tight” or “leaky” epithelia. A good example of a leaky
epithelium is that of the mammalian proximal tubule with TER ~6 Ω.cm2, and an
example of a tight epithelium is that of a toad urinary bladder with TER ~300,000 Ω.cm2.
The physiological significance of the differences in TER becomes evident when we look
at the specific function of the epithelium. In the distal nephron, the “tight” TJ are
responsible for maintaining high electrochemical gradient generated by the active
transcellular transport. Except colon all the segments of gastrointestinal tract are leaky, as
higher concentration gradients are to be maintained for reabsorption of NaCl and water
and hence exhibit a higher resistance.
In most cases, the tightness of the epithelia correlated with the number of TJ
strands, where tight TJ had more than five strands while the leaky TJ had one single
strand. Here it was believed that the resistance of each strand was in series with that of
the other strands which is basically the sum of resistances of all the strands and hence has
a linear relationship. This was not true in the case of two strains of MDCK, which
exhibited several fold difference in TER although they had same number of TJ strands.
Size and Charge Selectivity
Another model suggested that TJ strands were assumed to be pores that can be
open or closed. As TER is measured instantaneously, the resistance was believed to be
proportional to the open probability of TJ pores raised to the negative power of number
of TJ strands. But this could neither explain the paracellular charge selectivity of different
epithelia nor the size selectivity within the same epithelium. It was seen that, along the
crypt villus axis in rat jejunum, there was an apparent difference in size selectivity. The
upper villus portion allows solutes of radii up to ~6 A0, the lower villus allows solutes of
radii up to ~10 A0 while the crypt allows much larger solutes with radii up to ~60 A0.
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Caco-2 cell line known to exhibit villous differentiation has been shown to have 3 distinct
pathways similar to that of rat jejunum. These include one that allows passage of
molecules with radii less than 4 A0, one that allows passage of molecules of radii 6.5 A0
and one that allows paracellular transport of much larger non-charged molecules.
Pore and Leak Pathways
From several studies performed later on to characterize the size selectivity of
different epithelia, it was discovered that the paracellular route of transport in itself has
two distinct pathways referred to as pore and leak pathways. These two pathways
together contribute to the gate function on the TJ.
According to the two pathway model (21) (Figure 1-2), pore pathway is a high
capacity, charge selective pathway that allows passage of small ions and solutes less than
~4 A0 in size. Since this pathway is capable of ionic charge discrimination, it is
responsible for carrying most of the electrical current during transport. It is now known
that a subset of claudins, have the capability to form pores that confer size and charge
selectivity. It is the composition of claudins that determines the charge selectivity of the
epithelial barrier.
Leak pathway is a low and non-charge selective pathway that allows passage of
larger solutes. Solutes larger than ~4 A0 in size are transported through the leak pathway.
Flux studies using tracers like mannitol (4.2 A0) and inulin (15 A0 ) represents
permeability through the leak pathway. It has been observed that the proinflammatory
cytokines can increase flux through the leak pathway without altering the pore pathway.
Regulation of this non-pore pathway is known to involve myosin light chain kinase
activity and dynamics of cytoskeleton.
Measurement of Electrical Resistance, Size and Charge Selectivity
TER is a measure of the flux of all ions across the epithelium which is best
represented in leaky epithelia where ion conductance across TJ is far greater than that of
apical and basolateral membranes. Na+ and Cl- are the most common ions present in the
physiological solutions and they do not discriminate between pore and leak pathways.
Any change in either of the pathways reflects in TER. Hence TER cannot be used to
study size and charge selectivity of the epithelium.
Charge selectivity can be studied by dilution potential technique. Creating an
electrochemical gradient by isosmotic alteration of NaCl concentration across the
epithelium provides a new equilibrium potential now based on the relative permeability
of Na+ and Cl− ions. Permeability ratio ranges from 10 to 0.1 in different epithelia.
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Figure 1-2.

Two-Pathway Model.

Permeability of non-charged polyethylene glycol molecules of various sizes across an
epithelium is plotted against their radius. The pathway for molecules smaller than 4 A0 in
diameter, referred to as pore pathway, is dictated by size and charge selective claudins.
The pathway for molecules larger than 4 A0 in diameter, referred to as a leak pathway, is
not charge selective and is governed by the status of cell-cell adhesion and cytoskeleton.
Source: Reprinted with permission. Anderson, J. M., and Van Itallie, C. M. (2009)
Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 1,
a002584. Copyright © 2009 Cold Spring Harbor Laboratory Press.
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Bi-ionic substitution is a technique used to determine the charge selectivity of the
barrier. This involves replacement of Na+ on one side of the epithelium with organic
cations of various sizes, measuring the permeability of each organic cation, which in turn
determines the size selectivity of pore pathway. Permeability through the leak pathway
can be determined by measuring flux of large tracer molecules like mannitol, sucrose,
and inulin. Polymers of varying sizes such as polyethylene glycols or dextrans are also
widely used to determine paracellular permeability.
Architecture of TJ
The typical architecture of TJ involves integral membrane proteins of three major
families: transmembrane associated marvel protein family (TAMP) comprising of
occludin, tricellulin and marvel D3 (1), claudin family and immunoglobulin superfamily
members such as junction adhesion molecules (JAMs) (8). A perijunctional actomyosin
ring comprising of a thick band of actin and myosin II is present just below the TJ. The
C-terminal domains of the integral proteins interact with intracellular PDZ-domain
containing scaffolding proteins such as ZO-1, ZO-2 and ZO-3, which in turn crosslink
membrane proteins with actin cytoskeleton (2-4) (Figure 1-3). TJ protein complex
recruits classic-signaling molecules like PKCs, c-Src, c-Yes, PP2A, PP1 and transcription
factors like ZONAB, thus forming a regulatory platform for mediating responses to
extracellular and intracellular stimuli (14).
TAMPS
This family of TJ proteins includes occludin, tricellulin (also called MarvelD2)
and Marvel D3. These proteins have a conserved MARVEL (MAL and related proteins
for vesicle trafficking and membrane link) domain with four transmembrane domains
linked by two extracellular (EL) loops and one intracellular loop (IL) (22). Occludin
forms homophilic interactions at the bicellular junctions via its extracellular domains.
Tricellulin is localized at tricellular junctions and is believed to form a barrier for macro
molecules (23). MarvelD3 is mainly localized at the bicellular junctions and is not
required for TJ formation (22).
Claudins
To date, this TJ protein family includes nearly 27 different claudins. Their domain
structure includes an intracellular N-terminus, a longer C-terminus, two extracellular
loops and an intracellular loop. The first extracellular loop consists of a signature
sequence and a C-terminus PDZ domain-binding motif, which interacts with ZO-1.
All claudins are barrier-forming proteins, however some claudins are considered
to be pore-forming based on their ability to increase paracellular permeability specifically
to molecules of certain size or charge but do not affect the barrier permeability to

6

Figure 1-3.

Tight Junction- a Multi-protein Complex.

Epithelial tight junctions comprise of integral transmembrane proteins such as occludin,
claudins, and junction adhesion molecules (JAM) that seal the paracellular space. The
intracellular tails of these membrane proteins interact with scaffolding proteins such as
ZO-1, ZO-2, ZO-3 which then cross link membrane proteins with the actin cytoskeleton.
Source: Reprinted with permission. Groschwitz, K. R., and Hogan, S. P. (2009) Intestinal
barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol
124, 3-20. Copyright © 2009 American Academy of Allergy, Asthma & Immunology.
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macromolecules. Claudin-2, -10b, 15 and 16 are known to be cationic pore forming
claudins while claudin-10a and -17 are anionic pore forming claudins. Mutations in these
genes are known to cause hereditary diseases (24). Claudin-2 is a well-studied cationic
pore forming claudin that is highly expressed in leaky TJ like that of proximal tubule and
intestinal crypts. In the proximal tubule, claudin-2 is responsible for passive reabsorption
of sodium (25,26).
Peripheral TJ Proteins
The intracellular scaffolding proteins include zonula occludens proteins (ZO-1,
ZO-2, ZO-3), MAGI proteins (MAGI1, MAGI2 and MAGI3), Par-3, Par-6, MUPP and
PatJ. The ZO proteins belong to the MAGUK (membrane-associated guanylate kinase
homologues) protein family as their domain composition includes 3 PDZ domains in the
N-terminus, a SH3 homology domain and a guanylate kinase domain. The guanylate
kinase domain of ZO-1 interacts with occludin c-terminus. Cingulin is associated with the
cytoplasmic surface of TJ and expressed during early embryogenesis and epithelial
maturation. Cingulin links TJ proteins to actin cytoskeleton via interactions with ZO
proteins and actin. ZONAB. Rab13 (27).
Occludin Structure
Occludin is expressed in various epithelial cells but is not detectable in
fibroblasts. Human occludin gene was mapped to chromosome band 5q.13.1. Nearly 90%
homology exists among mammalian occludins (20). The multidomain tetra span structure
includes four transmembrane domains (TM), two extracellular loops (EL1 & EL2), a
cytoplasmic short N-terminus and an extended C-terminus. EL1 and EL2 are involved in
cis and trans homophilic interactions (28). The coiled coil domain in occludin C-terminus
interacts directly with the guanylate kinase-like (GUK) domain of ZO-1 (29). Nearly half
of the 522 amino acid residues of occludin (266-522) are present in its C-terminus and is
a known target for several kinases and phosphatases (30). Multiple bands of occludin are
often detected by immunoblot analysis, which are believed to be phosphorylated forms of
occludin. Most of the studies were performed using antibodies that detect occludin band
around 65 kDa.
Occludin C-terminus Harbors a Conserved Phosphorylation Hot Spot
Structural analysis of occludin C-terminus (383-522) revealed that the distal part
of this domain, comprising of amino acids from 416 to 522, is involved in an ordered
coiled-coil structure that interacts with ZO-1 while the region comprising of N-terminus
34 amino acids is disordered (31). This proximal disordered region includes a sequence
of amino acids highly conserved among mammalian species. Most notably this includes a
phosphorylation hotspot stretching from Y-398 to S-408.
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Occludin Regulatory Motif (ORM)
Previous studies showed that occludin undergoes tyrosine phosphorylation that
regulates its interaction with ZO-1 during H2O2 induced TJ disruption (32,33). Elias et al
highlighted the presence of a highly conserved phosphorylation hot spot (Y398-S408) in
occludin C-terminus (Figure 1-4A) and identified that phosphorylation of Y-398 and Y402 attenuates its interaction with ZO-1 (34). Suzuki et al showed that PKCη mediated
phosphorylation of T403 and T404 is involved in the regulation of epithelial TJ (35). It
was believed that tyrosine phosphorylation (Y-398, Y-402) by c-Src, destabilizes TJ
whereas threonine phosphorylation (T403, T404) by PKCζ and PKCη promotes TJ
assembly (36). Studies by Turner group demonstrated the role of S408 phosphorylation in
the regulation of barrier function (37). Later on, Dorfel et al showed that CK2-mediated
serine/threonine phosphorylation of the T400-XXX-T404-XXX-S408 motif regulates TJ
modulation (38). Although the structure of this phosphorylation hot spot (Y398-S408)
was not resolved by crystallography, based on the observations that this region is a target
for phosphorylation mediated TJ regulation, we considered this motif a functional
component of occludin and coined the term “occludin regulatory motif” (ORM) (Figure
1-4B).
Occludin Function
Overexpression of occludin in insect cells resulted in occludin localization at the
intracellular multi-lamellar bodies similar to TJ (39). Expression of occludin in MDCK
cells resulted in occludin localization at intercellular junctions with increased TER and
increased paracellular permeability (40). Occludin expression in fibroblasts that are
occludin deficient but express ZO-1 and AJ proteins, occludin was localized at cell-cell
contacts and conferred cell adhesion (19). These data suggested that occludin is required
for formation of TJ. However, alteration of both alleles of occludin in embryonic stem
cells did not prevent formation of TJ strands, suggesting that other TJ associated proteins
can form TJ strands even in the absence of occludin (41).
Saitou et al generated occludin -/-mice that carried a null mutation in occludin
gene, to study its function in vivo. The heterozygous and homozygous mutant mice were
viable with no gross phenotype at birth but exhibited post-natal growth retardation. There
were no significant changes in the formation of TJ strands (in terms of their number, size
and appearance) in mutant mice compared to wild type mice, as visualized by ultrathinsection electron microscopy and freeze fracture replica electron microscopy. TJ were
similarly not affected in kidney or liver of the occludin -/- mice. TER of the small and
large intestinal epithelial layers was low in mutant mice but not statistically significant.
Histological examination revealed chronic inflammation and hyperplasia in occludin -/mice. Calcification in the brain, thinning of the bone and male infertility were also
observed in occludin -/- mice (42). These data together suggested that occludin gene is
indispensable and the complex phenotype seen its absence is probably due to an
unidentified function of occludin.
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Figure 1-4.

Conserved-phosphorylation Hot Spot in Occudin C-terminus.

A. Sequence alignment of a portion of Occludin C-terminus showing highly conserved region among various species. B. Domain
structure of occludin with two extracellular loops (EL1 & EL2), an intracellular loop (IL), four transmembrane domains(TM1-4),
intracellular N and C-terminii. Distal region of occludin with phosphosites Y398-S408 is termed as occludin regulatory motif (ORM)
Source: Reprinted with permission. Cummins, P. M. (2012). "Occludin: one protein, many forms." Mol Cell Biol 32(2): 242-250.
Copyright © 2012, American Society for Microbiology.
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Occludin was shown to form a complex with extrinsic death receptor and induce
apoptosis in epithelial cells (43). Occludin downregulation by siRNA in human
keratinocytes reduced cell-cell adhesion and susceptibility to apoptosis and altered Ca2+
homeostasis and cell differentiation (44). Occludin overexpression and knockdown
altered TNF mediated changes in barrier function indicating that occludin is required for
cytokine-mediated TJ regulation (45).
TJ- a Dynamic Multi-Protein Complex at Steady State
Studies by Turner group have demonstrated that the TJ multiprotein complex is
highly dynamic at steady state. Extensive FRAP (Fluorescence recovery after
photobleaching) based experiments were performed by Shen et al., in MDCK cell
monolayers expressing EGFP tagged occludin/ZO-1/claudin-1/β-actin (3). Fluorescence
recovery analyses of each of these proteins revealed that most of the TJ-associated
occludin is highly mobile (mobile fraction 71±3%) with a slow exchange between
bleached and fluorescent pools of occludin and a t1/2 of 194 ± 19s. ZO-1 mobility is
similar to that occludin (mobile fraction 69±5%) but exchanges more rapidly than
occludin with a t1/2 of 119 ± 21s. Although occludin interacts with ZO-1, these two TJ
proteins do not exchange as a complex and have distinct dynamic behavior. On the other
hand, claudin-1 has relatively low mobility (mobile fraction 71±3%) and hence only a
small fraction of TJ associated claudin-1 is available for exchange. β-actin which is
known to be highly dynamic, has a mobility that is higher than the three TJ proteins
(mobile fraction 98±6%) and a t1/2 of 106 ± 18 (Table 1-1).
Occludin Exchange Occurs by Diffusion within and Between TJ and Lateral
Membrane
In order to determine whether the diffusion during FRAP occurs within the
membrane associated TJ or intracellular pools; further analyses by interfering with
membrane fluidity, cellular ATP levels and vesicular transport were performed. Reducing
the temperature of cell monolayers from 37°C to 14°C, reduced the mobility of occludin.
This was due to the low temperature mediated stabilization of cholesterol rich TJ
membrane domains. Because endocytosis of occludin was shown to be involved in
cytokine mediated TJ regulation, it was believed that fluorescence recovery of occludin
was mediated by vesicular transport. But neither ATP depletion, nor treatment with a
guanine exchange factor inhibitor affected occludin kinetics, suggesting that occludin
exchange does not involve vesicular transport. On the other hand, methyl-B-cyclodextrin
(MDCD)-mediated cholesterol depletion blocked occludin fluorescence recovery. FLIP
(Fluorescence loss in photobleaching) analysis was used to assess the exchange between
morphologically distinct protein pools of the TJ. FLIP analyses showed that continuous
photobleaching of cytoplasm did not affect fluorescence loss at TJ, but photobleaching at
the TJ resulted in fluorescence loss in the regions adjacent to the photobleached region.
These data together suggest that occludin fluorescence recovery is mediated by diffusion
within the membrane and the membrane fluidity plays an important role in its mobility.
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Table 1-1.

Dynamic Behavior of TJ Proteins.
TJ Protein
Occludin

ZO-1

Claudin-1

Protein Pools
Tight junction
-Mobile
-Immobile

Value (%)
80
80
0

Lateral membrane
-Mobile
-Immobile

20
20
0

Intracellular

0

Tight junction
-Mobile
-Immobile

40
25
15

Lateral membrane

0

Intracellular

60

Tight junction
-Mobile
-Immobile

100
40
60

Lateral membrane

0

Intracellular

0

Source: Modified with permission. Shen, L., Weber, C. R., and Turner, J. R. (2008) The
tight junction protein complex undergoes rapid and continuous molecular remodeling at
steady state. J Cell Biol 181, 683-695. Copyright © 2008 Shen et al.
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80% of occludin is present within the TJ while 20% is present at the lateral membrane.
Interestingly, both these fractions are mobile. The confocal imaging of cells expressing
EGFP-occludin shows occludin localized at TJ and also along the lateral membrane just
below the TJ. The diffusion constant of occludin associated with TJ pool was found to be
0.011 µm2s-1 while that of the occludin associated with the lateral membrane was found to
be 0.1 µm2s-1. These data suggest that the diffusion of lateral membrane occludin is faster
than that present at the TJ. Thus occludin exchange occurs by diffusion within and
between TJ and lateral membrane.
ZO-1 Exchanges with an Intracellular Pool
Similar studies performed in cells expressing EGFP-ZO-1 showed that ZO-1 is
highly mobile within the TJ. Cholesterol depletion by MBCD had no effect on ZO-1
mobility but depletion of cellular ATP and continuous photobleaching of cytoplasm
reduced fluorescence recovery of ZO-1. These data together indicate that a large fraction
of TJ associated ZO-1 exchanges with an intracellular pool in an energy dependent
mechanism.
Claudin-1 Exchange Occurs by Diffusion within the Membrane
Claudin-1 on the other hand is less mobile as the fluorescence recovery is low
after photobleaching. Continuous photobleaching of TJ resulted in rapid loss of claudin-1
fluorescence from junctions while that of cytoplasm had no effect. These data indicate
that a small fraction of claudin-1 exchange occurs by diffusion within the TJ.
These observations strongly suggest that the TJ components are highly dynamic,
and that such dynamic properties have the potential to regulate paracellular permeability
via the fine-tuning of signaling cascades involved in barrier function (5). Understanding
TJ dynamics will unravel TJ components as targets for the development of therapeutic
agents aimed at modulating barrier function.
TJ Regulation by Occludin Phosphorylation
TJ regulation occurs in health as well as disease. Besides forming a seal that
maintains the compartmentation, TJ serve to regulate the paracellular transport under
various physiological and pathophysiological conditions. Several stimuli and signaling
molecules have been reported to regulate the later function of TJ. Occludin is known to
be an important target that mediates TJ regulation in these signaling cascades. TJ
modulation by occludin phosphorylation and dephosphorylation has been studied
extensively. The kinases and phosphatases involved are listed in (Table 1-2) Mutational
analyses pointed towards ORM and its role in TJ modulation (Table 1-3).
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Table 1-2.

Kinases and Phosphatases Associated with Occludin Phosphorylation.

Phosphatase
/Kinase
CK1

Experimental Model

Phosphosite

Reference

HUVEC
GST-Ocl-C (Human)

Thr, Ser
Thr, Ser

(46)
(23)

CK2

Xenopus laevis embryo
GST-Ocl-C (Human)
Caco-2

Thr 375, Ser 379
Thr-400/404, Ser 408
Ser 408

(47)
(38)
(37)

c-Src

Rat-1, MDCK
Caco-2

Tyr-398, Tyr-402
Tyr

(34)
(33)

c-Yes

MDCK

Tyr

(48)

PKCη

Caco-2, MDCK

Thr-403, Thr-404

(35)

PP2A

GST-Ocl-C (Human), Caco-2
MDCK

Ser, Thr
Thr

(49)
(50)

PP1

Caco-2, GST-Ocl-C (Chicken)

Ser

(49)

DEP-1

MDCK

Tyr

(51)

PI3K

Caco-2, GST-Ocl-C (Chicken)

Tyr

(52)

Source: Reprinted with permission. Cummins, P. M. (2012). "Occludin: one protein,
many forms." Mol Cell Biol 32(2): 242-250. Copyright © 2012, American Society for
Microbiology.
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Table 1-3.
Kinase
c-Src

PKCη

CK2

Mutation Analyses of Phosphorylation Hotspot in Occludin.
Mutation
Y398/402D

Effect on TJ
TJ-assembly ↓
Inulin permeability ↑
Junctional occludin ↓
Interaction with ZO-1↓

Y398/402A

Junctional occludin↑
TJ-assembly→
Inulin permeability→

T403/404D

TER ↑
Inulin permeability ↓
Junctional occludin↑

T403/404A

TER↓
Junctional occludin↓
Junctional ZO-1↓

S408A

Junctional occludin↑
Interaction with ZO-1 ↑
Occludin exchange ↓

S408D

Junctional occludin ↓
Interaction with ZO-1 ↓
Occludin exchange →

T404A/S408A

Occludin exchange ↓
Interaction with ZO-1 ↑
TER↑

T400A/T404A/
S408A

Interaction with ZO-2↓
TJ-assembly ↓

Model
Caco-2
MDCK
Rat-1

Reference
(33,34,53)

Caco-2
MDCK

(35,54)

Caco-2
MDCK
T84

(37,38,47)

Source: Modified with permission. Dorfel, M. J. and O. Huber (2012). "Modulation of
tight junction structure and function by kinases and phosphatases targeting occludin." J
Biomed Biotechnol 2012: 807356. Copyright © 2012 Max Johannes Dörfel and Otmar
Huber.
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Kinases
c-Yes. Tyrosine kinase, c-Yes was pulled down with the peptide that mimics
coiled-coil domain of occludin indicating a direct interaction between c-Yes and occludin
(55). C-Yes induced-dephosphorylation of tyrosine residues during Ca2+ depletion
mediated TJ disassembly in MDCK-II cells, was attenuated by c-Yes inhibitor
CGP77675. Hence c-Yes was believed to be a barrier promoting kinase (48). However,
the phosphosites in occludin for c-Yes were not identified.
c-Src. Oxidative stress induced tyrosine phosphorylation of occludin and
redistribution of occludin and ZO-1 (56). Expression of a kinase inactive c-Src delayed
oxidative stress induced TJ disruption indicating that c-Src was the potential tyrosine
kinase involved. c-Src was found to interact with GST tagged occludin c-terminus in
vitro which decreased interaction between occludin and ZO-1 (33). Y398 and Y402
present in a highly conserved motif YETDYTT were identified as the phosphosites for cSrc (34). A phosphomimetic mutation of Y398/402D in occludin attenuated its
interaction with ZO-1, delayed TJ reassembly during Ca2+ switch in MDCK cells and
sensitized them to hydrogen peroxide induced barrier dysfunction (34).
FAK. Focal adhesion kinase plays a key role in the regulation of cytoskeleton,
cell migration and adhesion. Acetaldehyde treatment in human colonic biopsies resulted
in the activation of FAK, increased tyrosine phosphorylation of occludin and ZO-1 and
redistribution of occludin from intercellular junctions. EGF or glutamine pretreatment
was able to prevent these effects.
PKCη. Over expression of constitutively active PKCη in Caco-2 and MDCK
cells enhanced barrier function by increasing TER, decreasing inulin-flux and increased
occludin localization at the intercellular junctions. These effects were blocked by the use
of PKCη pseudosubstrate and shRNA-induced knockdown of PKCη. PKCη was shown
to interact with occludin. By mass spectrometry and mutational analyses, T403 and T404
were identified as the phsophosites for PKCη. T403A mutation partially blocked
phosphorylation whereas T404A completely prevented it. T403/404D mutation enhanced
occludin and ZO-1 localization at the intercellular junctions while T403/404A mutation
decreased ZO-1 localization at junctions and occludin was seen mostly in the intracellular
compartment (35).
PKCζ. Atypical PKC like was shown to interact with occludin C-terminus and
phosphorylate T403, T404, T424 and T438. Inhibition of PKCζ using pseudosubstrate
led in MDCK and Caco-2 cell led to decrease in TER, increase in permeability, decreased
occludin phosphorylation, redistribution of occludin from the junctions and delayed Ca2+
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induced TJ reassembly. Mutation of T424/438 to alanine resulted in occludin localization
in intracellular compartment and delayed Ca2+ induced TJ reassembly (57).
CK2. Casein kinase 2 is a tetrameric serine/threonine kinase with two catalytic
subunits(a,a’) and two regulatory b-subunits. In vitro phosphorylation studies revealed
that CK2 interacts with occludin and phosphorylates T400, T404 and S408. A triple
mutant T400A/T404A/S408A blocked complete phosphorylation of occludin in vitro. In
Caco-2 cells, knockdown of CK2 or pretreatment with CK2 inhibitors enhanced barrier
function by increasing TER and decreasing paracellular flux of sodium ions. FRAP
studies using occludin knockdown-Caco-2 cells expressing EGFP-occludin showed that
CK2 inhibition reduced mobile fraction of occludin. Mutants S408A and T404A/S408A
showed decreased mobility compared to wild type occludin, S408D and T404D/S408D
mutants (38). It was postulated that S408 phosphorylation might act as a switch that
regulates TJ permeability by determining whether occludin forms homodimers or
heteromeric interactions with ZO-1, claudin-1 and claudin-2 (37).
PI3K. Phosphatidyl inositol-3 kinase, regulatory subunit p85 was found to
directly interact with coiled-coil domain of occludin c-terminus (55). Oxidative stress
induces translocation of p85 to the junctions and increased association with occludin.
Treatment of T84 cell monolayers with LY294002, a PI3K inhibitor, attenuated tyrosine
phosphorylation of occludin, decrease in TER, increase in permeability and redistribution
of occludin and ZO-1 from the junctions (52). Hence it was believed that PI3K activity is
involved in dissociation of TJ during oxidative stress.
Phosphatases
PP2A and PP1. Protein phosphatase 2A and 1 (PP2A and PP1) are
serine/threonine phosphatases ubiquitously expressed and associated with multiple
functions. In MDCK cells, enhanced PP2A activity induced dephosphorylation of
occludin and increased paracellular permeability which was attenuated by pretreatment
with okadaic acid, a PP2A inhibitor (50). In Caco-2 cells, inhibition of PP2A activity by
okadaic acid and fostriecin, resulted in enhanced TJ reassembly after Ca2+ switch.
SiRNA-mediated reduction of PP2A activity enhanced Ca2+ induced increase in TER,
decrease in inulin permeability and enhanced junctional localization of occludin and ZO1 during TJ reassembly. By in vitro assays it was found that PP2A dephosphorylates
phospho-occludin on threonine residues while PP1 dephosphorylates on serine residues.
Both PP2A and PP1 were found to interact with occludin C-terminus and negatively
regulate TJ assembly (49).
PP2A was also shown to be involved in hydrogen peroxide induced TJ disruption
in Caco-2 cell monolayers. Hydrogen peroxide enhanced association between occludin
and PP2A in Caco-2 cells, which was blocked by a SC kinase inhibitor, PP1 suggesting
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that this interaction is a tyrosine kinase dependent mechanism (58). Acetaldyde induced
TJ disruption also involves dephosphorylation of occludin by PP2A in Caco2 cell
monolayers. Acetaldehyde treatment increased translocation of PP2A to TJ and induced
threonine dephosphorylation of occludin (59).
DEP1. (Density-enhanced protein tyrosine phosphatase-1) has been shown to
interact with occludin in MDCK-II cells. Overexpression of DEP-1 in these cells led to
increased TJ reassembly and enhanced barrier function. Knockdown of DEP-1 resulted in
increased permeability (51).
Cytokine-induced TJ Regulation Involves Occludin
Modulation of TJ without altering TJ protein expression has been shown to occur
during physiological regulation of TJ by SGLT-1 (Sodium glucose transporter-1) and
pathophysiological regulation of TJ by proinflammatory cytokines like TNF and IL1-β.
Myosin light chain kinase (MCLK) is the key player underlying these processes. Na+glucose cotransport activation leads to MLCK mediated phosphorylation of MLC. This
leads to perijunctional actomyosin contraction and increased paracellular permeability.
TNF also induces activation of MLCK, which in turn induces actomyosin condensation
by MLC phosphorylation and increases paracellular permeability. Exposure to T-cell
derived cytokines in intestinal epithelial cells leads to caveolin mediated endocytosis of
occludin as a result of MLCK activation. This effect was blocked by inhibition of MLCK
as well as by drugs that block caveolar pathway.
In mice expressing EGFP-tagged occludin, exposure of the intestinal epithelium
to TNF induced focal accumulation of occludin, which was blocked by inhibitors of
caveolar pathway. These data suggested that TNF induced TJ regulation involves
endocytosis of occludin. In HT-29/B9 cells, TNF and interferon-gamma exposure
diminished occludin promoter activity, which resulted in enhanced paracellular
permeability associated with occludin downregulation (60).
VEGF
Vascular endothelial growth factor (VEGF) is known to be an important mediator
of vascular permeability and TJ deregulation in blood-brain and blood-retinal barriers.
VEGF was found to induce phosphorylation of S490 of occludin (61). This enhances
interaction with E3 ubiquitin ligase and induces occludin ubiquitination. VEGF induced
occludin phosphorylation in BRECs resulted in increased permeability and decreased
TER (30). Thus VEGF alters TJ and increases vascular permeability in brain and retinal
disorders. Human intestinal adenocarcinoma was shown to exhibit decreased occludin
expression and tumor derived VEGF is known to play an important role in occludin
degradation and tumor metastasis (28).

18

Occludin Variants
Occludin is known to exhibit functional diversity by means of its variants
generated by gene splicing and alternate promoter usage. Saitou et al (62) were the first
to report isoforms of occludin, generated by alternative splicing.
Occludin with N-terminus Extension
Occludin 1B, originally identified in MDCK cells is an alternatively spliced
variant with a 193-bp insertion that encodes an occludin isoform with a 56 amino acid Nterminal extension (63). This was later found to be expressed in human colon carcinoma
cells and mouse intestine. It was known to localize at the junctions similar to wild type
occludin. The extended N-terminus of occludin 1B was believed to mask the SH3 motif
and hinder binding interactions with SH3 adaptor proteins.
Occludin with TM4 Deletion
TM4 (-), identified in human tissues, embryos, epithelial and endothelial cells, is
an isoform generated by skipping exon 4 leading to a 162-bp deletion that encodes TM4
and proximal c-terminus region. TM4 (-) also referred to as type II occludin, failed to
localize at the junctions because of the externalized C-terminus, and does not colocalize
with ZO-1. It was believed that low-level expression of TM4 (-) occurs during tissue
remodeling,
Occludin with Alternate Promoter (Exon 1a)
This variant was known to be generated using second occludin promoter and
transcription start site (exon 1a). It has enhanced sensitivity TNF signaling and believed
to have a pathological role inducing colonic inflammation in ulcerative colitis.
Occludin with Alternate Promoter and Exon 9 Deletion
OccΔE9 was identified in human liver cells. This isoform localized in the
cytoplasm and failed to induce apoptosis like the canonical occludin and hence was
speculated to have a role in metastasis.
Significance
Although the studies so far did not confirm the functional significance of these
occludin variants, it is strongly believed that they are expressed under conditions of
physiological regulation of TJ or during disease pathogenesis and cancer progression.
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Occludin in Disease Pathogenesis
Occludin is an important target during barrier breach and hence is associated with
several disease processes. In all these cases occludin is subjected to either
downregulation or altered subcellular localization.
Diarrhea
Pathogenic toxins that target gastro intestinal tract mediate disease pathogenesis
by mechanisms that involve occludin and increase in paracellular permeability. Listed
below are some of the examples.
a. Gliadin exposure to intestinal biopsies from celiac patients increased permeability
to macromolecules by Zonulin release and loss of occludin-ZO1 interaction (64).
b. Enteropathogenic Escherichia coli (EPEC) secretes a protein called EspF that
increases intestinal permeability, reduces TER and dissociates occludin from TJ
by inducing dephosphorylation (65).
c. Clostridium perfringens enterotoxin (CPE) forms a large protein complex with
occludin that increases permeability and induces cytotoxicity in Caco-2 cells (66).
d. Vibrio cholera produces a cytotoxin, hemagglutinin/protease (HA/P) that causes
barrier dysfunction by degrading occludin and perturbing actin cytoskeleton in
MDCK-I cells. This leads to decrease in TER and loss of TJ strands (67).
e. Clostridium difficile toxins A and B are UDP-glucosyltransferases that
glucosylate and inactivate Rho. This induces cytoskeletal disorganization,
dissociation of occludin and ZO-1 from TJ and increases TJ permeability in T84
intestinal epithelial cells (68).
Inflammation
TJ barrier dysfunction associated increase in epithelial permeability is believed to
either predispose or enhance disease progression. Crohn’s disease and ulcerative colitis
are collectively referred to as inflammatory bowel disease (IBD). Patients with IBD
exhibit increased intestinal paracellular permeability and decreased occludin expression.
IBD pathogenesis involves production of a cytokine like tumor necrosis factor (TNF).
MLCK expression and activity were also enhanced in intestinal epithelium of IBD
patients. Thus TNF induced occludin downregulation and occludin endocytosis by
MLCK activation are the key mechanisms underlying barrier dysfunction mediated
disease progression.
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Cancer
TJ between cells confer cell-cell adhesion and maintain integrity of the
epithelium. Hence it is believed that the TJ disassembly is required for the cells of
neoplastic epithelium to metastasize. The process of metastasis involves TJ disruptionmediated detachment of tumor cell from its primary site, intravasation through the
endothelial barrier often induced by secretion of growth factors like VEGF, HGF and
extravasation of the circulating tumor cell leading to invasion of other tissues. The
following are the instances where occludin down regulation induced TJ dysfunction aids
in metastases of various tumors.
a. Tumors of rat and human colon showed increased permeability while histological
analysis of human intestinal adenocarcinomas showed reduced expression of
occludin. A correlation between tumor differentiation and occludin expression
was reported (69).
b. Hepatocyte growth factor or scatter factor (HGF/SF), a cytokine released by
stromal cells is known to increase paracellular permeability, decrease TER and
alter occludin expression in human breast cancer cell lines. Down regulation of
occludin is believed to play a role in metastasis of breast cancer cells (70).
c. In human endometrial cancer, with the increase in carcinoma grade, expression of
occludin was found to be decreased. Decreased occludin expression was also
found during invasion of the myometrium and lymph node metastasis (71).
Alcoholic Endotoxemia
Alcohol increases paracellular permeability to endotoxins in the gut. Alcohol
induced endotoxemia is involved in the pathogenesis of alcoholic liver disease (ALD)
(72). Ethanol and its metabolite acetaldehyde induced TJ and AJ disruption in Caco-2 cell
monolayers. Acetaldehyde treatment in these cells induced occludin redistribution from
intercellular junctions. This involved dephosphorylation of occludin on threonine
residues mediated by PP2A (59). In a recent study using occludin knock out mice, we
showed that lack of occludin exacerbates chronic ethanol-induced increase in colonic
mucosal permeability. Similarly, using shRNA mediated occludin knock down,
acetaldehyde exposure in Caco-2 cell monolayers was shown to enhance TJ disruption
and barrier dysfunction (73). These data suggest that occludin plays an important role in
barrier function and that its disruption sensitizes TJ to alcohol induced endotoxemia.
Hepatitis
Human occludin was identified as an important entry factor for hepatitis C virus
(HCV) infection. Occludin silencing impaired infection of lentiviral particles bearing
HCV glycoprotein (HCVpp) (74). A later study showed that occludin interacts with HCV
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glycoprotein (HCVgp). Occludin knock down led to reduced infection by cell culture
derived HCV particles. Thus occludin plays an essential role in HCVgp fusion at late
entry events of HCV infection (75). A recent study showed that HCV infection in
hepatoma cells induced an increase in occludin expression and upregulation of adiposedifferentiation related protein. (ADRP). In HCV-infected human livers, ADRP mRNA
expression levels correlated with that of occludin
Miscellaneous
a. Oncogenic Raf1 mediated tumorigenesis causes downregulation of occludin in rat
salivary gland epithelial cells. The second extracellular loop of occludin is known
to be required for inhibition of Raf-1 mediated tumorigenesis in vitro and in vivo
(76,77).
b. Ras-transformed MDCK cells have loss of occludin and ZO-1 from TJ. This
increased TJ permeability is known to involve MAPK signaling pathway. Ras
mutations are known to cause barrier dysfunction by altering occludin and
claudin-1 levels at TJ (78).
c. Rho Kinase (RhoK) activation mediated occludin phosphorylation is associated
with barrier leakiness in the case of human immunodeficiency virus encephalitis
(HIVE) (79). Malignant brain tumors also displayed leaky endothelial TJ and loss
of occludin expression (80).
d. Helicobacter pylori sonicates are known to increase gastric permeability by
altering expression of occludin in a PKC dependent mechanism (28).
e. A discontinuous staining pattern of occludin in blood brain endothelium is
considered a hallmark of HIVE (HIV associated encephalitis) (79).
f. Serum from multiple sclerosis patients induced downregulation of occludin in
cultured endothelial cells (81).
Hypothesis and Specific Aims
Epithelial TJ serve as a critical intercellular barrier against paracellular
permeation of luminal antigens, toxins and pathogens. TJ disruption-induced increase in
paracellular permeability leads to edema, jaundice, enterocolitis, alcoholic endotoxemia,
IBD, celiac disease and colon cancer. Hence understanding the dynamic nature of TJ
barrier is crucial to determine their physiological role in normal development and during
pathogenesis.
TJ is known to be a highly dynamic multi-protein complex with its components
occludin, claudins and ZO-1, each exhibiting a unique dynamic behavior. Yet, the
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contributing factors for this dynamic nature remain elusive. It is well accepted that
occludin phosphorylation in a highly conserved region (Tyr398-Ser408), which we call
ORM, plays a role in TJ regulation. However, the function of this motif in TJ dynamics is
not well defined.
Hypothesis
Based on the above observations, we hypothesized that ORM confers dynamics to
epithelial TJ and regulates barrier function by ORM-mediated protein-protein
interactions. Our goal is to investigate the functional significance of ORM and ORMmediated signaling mechanisms that underlie TJ regulation. This goal will be achieved by
conducting studies under the following specific aims.
Specific Aim 1: To Determine That ORM Confers Dynamics to TJ in a
Phosphorylation-dependent Mechanism
Studies designed here were aimed to determine the function of ORM in TJ
dynamic using a deletion mutant of occludin that lacks ORM. Furthermore, double pointmutants of occludin phosphosites were used to establish the significance of ORM
mediated phosphorylation in TJ dynamics.
Specific Aim 2: To Determine That ORM-mediated Protein Interactions Are
Involved in TJ Modulation
Studies designed here were aimed to identify the proteins that interact with ORM,
using a synthetic peptide that mimicked ORM. Furthermore, the functional significance
of ORM-mediated protein interactions was established in relation to TJ modulation.
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CHAPTER 2.

MATERIALS AND METHODS

Cell Culture and Transfection
Cell Lines
Madin-Darby canine kidney (MDCK) cell line was originally derived from kidney
tissue of a normal adult female dog. These cells are known to exhibit apico-basolateral
polarity and well-defined cell junctions. Hence they have been widely used to study tight
junctions, protein trafficking and polarity associated with epithelial cells. MDCK cells
were purchased from American Type Cell Culture (ATCC). They were grown in
Dulbecco’s modification of eagle’s medium (DMEM) supplemented with 10% (v/v) fetal
bovine serum (FBS), 1mg/10ml primocin and maintained at 370C and 5% carbon dioxide
(CO2).
Caco-2 cells were isolated from adenocarcinoma of a 72-year old Caucasian male.
These cells after differentiation are known to express brush border enzymes and
microvilli on their apical membrane. Caco-2 cells are widely used to study intestinal
permeability and cell signaling, as they closely resemble the intestinal epithelium when
grown on polycarbonate transwell inserts. Hence this cell line is treated as an ideal model
to study intestinal barrier function. Caco-2 cells were purchased from American Type
Cell Culture (ATCC). They were grown in Dulbecco’s modification of eagle’s medium
(DMEM) supplemented with 20% (v/v) fetal bovine serum (FBS), 1mg/10ml primocin
and maintained at 370C and 5% carbon dioxide (CO2).
Occludin Gene Silencing
For occludin gene silencing in canine MDCK cells, vector-based short hairpin
RNA (shRNA) was designed using the Dharmacon Web site (siDesign® Center,
http://www.dharmacon.com/DesignCenter/) and cloned into pRNAtin-U6 vector
(GenScript). Two targeting sequences were chosen against the nucleotide sequence of
canine occludin gene using the Dharmacon web site (Target1:
TATGTCAGACCTTATAACG; Target2: TATGCTACCACCCATTAAG). The
sequences were further verified by BLAST search on the known human genome
database, and no matches were found confirming the uniqueness of these sequences.
To construct the shRNA vectors, two pairs of oligonucleotides containing the
antisense sequence, a hairpin loop region (TTGATATCCG), and the sense sequence with
cohesive BamHI and XhoI sites were synthesized (Sigma Genosys, St Louis, MO) using
the primers provided in the table (Table 2-1). The top and bottom strands were annealed
and cloned into BamHI and XhoI sites of the pRNAtin-U6 vector (GenScript Corp.,
Piscataway, NJ) (pR vector), which induces expression of shRNA by U6 promoter.
Successful insertion of the shRNA constructs into the vector was confirmed by releasing
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Table 2-1.

Primers for Knockdown and Mutation of Occludin.

Primer
cOCN-shRNA1-Top strand
cOCN-shRNA1-bottom strand
cOCN-shRNA2-Top strand
cOCN-shRNA2-bottom strand
Δ388-415 Forward
Δ388-415 Reverse
Y398/402A
Y398/402D
T403/404A
T403/404D
T400/403/404A
T400/403/404D

Sequence
GATCCCGTATGTCAGACCTTATAACGTTGA
TATCCGCGTTATAAGGTCTGACATATTTTTT
CCAAA
AGCTTTTGGAAAAAATATGTCAGACCTTAT
AACGCGGATATCAACGTTATAAGGTCTGAC
ATACGG
GATCCCGTATGCTACCACCCATTAAGTTGA
TATCCGCTTAATGGGTGGTAGCATATTTTT
TCCAAA
AGCTTTTGGAAAAAATATGCTACCACCCAT
TAAGCGGATATCAACTTAATGGGTGGTAGC
ATACGG
TGGATCAGGGAATATCCACCTATCA
TGCTCTTCCCTTTGCAGGTGCTCT
CAGAGCAAGATCACGCTGAGACAGACGC
CACAACTGGCGGCGAG
CAGAGCAAGATCACGATGAGACAGACGA
CACAACTGGCGGCGAG
CAAGATCACTATGAGACAGACTACGCAGC
CTATGATCACTATGAGACAGACTACGATG
ATGGC
GATCACTATGAGGCAGACTACGCAGCTGG
CGGCG
CTATGATCACTATGAGGATGACTACGATGA
TGGCGGCGAGTCC

Note: pEGFP occludin wild type construct was used as the template for all mutations
except T403/404A and T403/404D, where templates were T400/403/404A and
T400/403/404D respectively.
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the oligonucleotides by digesting with BamHI and XhoI and sequencing. For a control, a
mutant form of shRNA was designed by replacing adenine and guanine nucleotides with
cytosine and adenine, respectively.
ORM Deletion Mutation
ORM deletion mutant was generated in a pEGFP-human occludin construct by
inverse PCR using primers flanking the ORM region. The PCR product was treated with
DPn1 to digest the plasmid DNA and a self-ligation was performed by a reaction with T4
polynucleotide kinase and T4 DNA ligase (New England Biolabs Inc., Beverly, MA).
The mutation was confirmed by restriction digestion, PCR amplification and sequencing.
The mutant construct was transformed into XL10 gold competent cells for DNA
amplification. This resulted in a deletion mutant of occludin (OclDM: Δ388-415) lacking 28
amino acids (GRSKRTEQDHYETDYTTGGESCDELEED) in its C-terminus.
Transfection
Stable clone of occludin knock down MDCK cell line (OD-MDCK) generated by
shRNA transfection were grown in Dulbecco's modified Eagle's medium supplemented
with 10% fetal bovine serum (Gibco), primocin (100ug/ml; Invivogen) and hygromycin
(100ug/ml; Thermo Fischer). The constructs pEGFP-occludinWT, pEGFP-occludinDM or
vector alone were transfected into OD-MDCK cells using lipofectamine 2000
(Invitrogen). Stable clones of OD-MDCKWT, OD-MDCKDM and OD-MDCK-Vec were
generated by G418 mediated selection and dilution cloning. At least 12 clones from each
group were screened for GFP fluorescence by live-cell confocal imaging and protein
expression by western blot analysis.
Fluorescence Microscopy
Immunofluorescent Staining
Cell monolayers or tissue cryosections were fixed in either acetone/ methanol
(1:1) at 0 °C for 5 min or 3% paraformaldehyde (for staining actin-cytoskeleton) at room
temperature for 15 min. Those fixed in acetone/methanol were stored at -20 °C while
those fixed in paraformaldehyde were stored in PBS at 4 °C for not more than a week. On
the day of staining, fixed monolayers or cryosections were washed twice with PBS and
permeabilized in 0.2% Triton X-100 for 10min. After washing three times with PBS, they
were blocked using 4% milk in TBST (20mM Tris, 150mM NaCl, pH 7.2) for 30 min at
room temperature. Then they were incubated with primary antibodies in 4% milk (antiZO-1, anti-GFP, anti-occludin, anti-MAP7, anti- β-tubulin, anti-E-Cadherin, anti-βcatenin) for 1 hour at room temperature. The monolayers were washed with 1% milk
followed by incubation with secondary antibodies (Alexa Fluor 488-conjugated anti-
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mouse and Cy3-conjugated anti-rabbit IgG) in 4% milk. Nuclear staining was done using
Hoechst 33342. F-actin and biotin were stained with AlexaFluor-488 conjugated
phalloidin and Cy3 conjugated streptavidin respectively. The monolayers were mounted
on a slide using mounting fluid and sealed for imaging.
Microscopy
•

Fluorescence was visualized in a Zeiss LSM 5 laser scanning confocal
microscope. The images from Z-series sections (1µm thickness) were collected by
Zen software. The z-series images were stacked by using the software, Image J
(National Institutes of Health), and processed by Adobe Photoshop (Adobe
Systems).

•

For time-course imaging studies, confluent cell monolayers grown in 60mm
culture plates were imaged using a 20X objective of the confocal microscope.
Cells were maintained in an incubator at 37 °C during the course of the
experiment. For cells in chamber slides, imaging was done by Nikon
epifluorescence microscope using a 40X objective.
Analysis of Barrier Function and TJ Integrity

Barrier Function Parameters
Cells were grown in transwell inserts (12mm; Costar) to achieve confluence at a
density of 3x 105 cells per well. The experiments were performed on days 1-4 in MDCK
cells and on days 7-10 in Caco-2 cells. Barrier function of the monolayers was monitored
by measuring electrical resistance of the barrier and unidirectional flux of FITC-inulin.
•

Trans-epithelial Electrical Resistance (TER) is a measure of the flux of all ions
across the epithelium. TER was measured by using a Millicell-ERS Electrical
Resistance System (Millipore, Bedford, MA). Basal TER of semi-permeable
membrane of transwells was subtracted from all values (80-100 Ohms/cm2).

•

Unidirectional FITC-inulin flux. FITC-inulin (6 kDa; 0.5 mg/ml) was
administered to the buffer in the apical well. At the end of incubation, 100 µl of
basal medium and 20 µl of apical medium were sampled, and fluorescence was
measured using an Flx-800 microplate fluorescence reader (BioTEK instruments,
Winooski, VT). Flux into the basal well was calculated as the percentage of total
apical well fluorescence/cm2 surface area.
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TJ Integrity
Cell monolayers were fixed in acetone/ methanol (1:1) for staining occludin, GFP,
ZO-1, E-cad, b-catenin and cld-2 while cells were fixed in 3% paraformaldehyde for
staining actin and tubulin. TJ integrity of the monolayers was analyzed by confocal
microscopy.
FRAP
FRAP (Fluorescence recovery after photo-bleaching) studies were performed
using a module available in the Zen software. The principle involved in FRAP is
represented in the schematic (Figure 2-1). Cells stably expressing GFP-tagged occludin
and its mutants were grown to confluence in 60mm culture plates. During imaging, cell
monolayers were washed and placed with DMEM without glutamine and phenol red. 3-4
regions of interest (ROI), provided in the module were defined at the intercellular
junctions of the monolayer. High intensity laser was used at 488nm to bleach the ROI,
with a specific number of iterations. The module was set to capture at least 3 images
before the bleach and time-lapse images up to ~25 min after the bleach.
All the images were collected at the same focal plane. The time series images
were processed by using ImageJ software and confirmed by manual calculation.
Fluorescent intensity was measured at varying times after bleaching to calculate percent
recovery. Percent recovered at 25 min was considered as percent mobile fraction.
Protein Analyses
Preparation of Triton-soluble and Triton-insoluble Fractions
Cell monolayers in 60mm culture plates were incubated with 500 µl lysis bufferCS (Tris buffer containing protease inhibitor cocktail (10ul/ml), 1 mM vanadate, and 1
mM PMSF) on ice for 15min. Cell lysates were centrifuged at 15,600 g for 4 min at 4°C
to sediment the high-density actin cytoskeleton. The supernatant was used as the tritonsoluble fraction.
The pellet that is known to contain membrane associated TJ components, was
suspended in 200 µl of lysis buffer-CS and sonicated to homogenize the actin
cytoskeleton. This was used as triton-insoluble fraction. Protein contents in both fractions
were measured by the BCA method (Pierce Biotechnology, Rockford, IL). The protein
fractions were mixed with equal volume of 2X Laemmli's sample buffer and heated at
100°C for 10 min.
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Figure 2-1.

Fluorescence Recovery after Photobleaching (FRAP).

A. Live-cell images of a confluent monolayer are captured before photobleaching. A high
intensity laser is used to bleach a specified region of interest (ROI) at intercellular
junctions. Time-lapse images post bleaching are captured until the fluorescence intensity
reaches a plateau. B. A plot of fluorescence intensity (I) versus time (t) gives a measure
of mobile (Fm) and immobile fractions (FI and half time of recovery (thalf).
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Immunoprecipitation
Confluent monolayers (60mm culture plates) were washed with ice-cold PBS and
proteins were extracted in 500ul ice-cold lysis buffer (10mM Tris/Cl pH 7.5 containing
150mM NaCl, 0.5mM EDTA, 0.5% NP40, 1mM PMSF, 1x Protease inhibitor cocktail).
The lysates were centrifuged at 15600g for 4 min at 4 °C. The supernatant was separated
and the pellet was resuspended in 200ul lysis buffer and sonicated for 10 sec to induce
fragmentation of F-actin filaments and release actin-bound TJ proteins. Previous studies
showed that nearly 80% of the occludin and ZO-1 was recovered in this fraction. This
was centrifuged at 13500rpm for 10 min and the supernatant was pooled with the
previous. The protein concentration was quantitated by BCA method. The total lysates
(1.0 mg protein/ml) were incubated with prewashed 25 ul GFP-Trap_A beads
(Chromotek, Germany) at 4 °C for 1 h. The immune complexes were isolated by
centrifugation at 2000g for 2 min at 4 °C, followed by washes with Tris buffer and
suspended in equal volume of Laemelli sample buffer (2 x concentrated). The protein was
extracted by heating the samples at 100 °C for 10 min and centrifuging at 13500 rpm for
10min. For immunoprecipitation of p-Thr, lysates were heated in the presence of 0.3%
SDS for 10 min at 100 °C followed by centrifugation. The clear supernatant was then
used for immunoprecipitation.
Immunoblot Analysis
Protein samples were separated by 7% SDS-polyacrylamide gel electrophoresis
and transferred to polyvinylidene diflouride (PVDF) membranes. Membranes were
blotted for occludin, ZO-1, GFP, actin, claudin-2, Peroxiredoxin 1 and MAP7 using
specific primary antibodies in combination with secondary HRP-conjugated anti-mouse
IgG or HRP-conjugated anti-rabbit IgG antibodies. GST was immunoblotted using HRPconjugated anti-GST antibody. The blots were developed using ECL chemi-luminescence
method (Amersham, Arlington Heights, IL).
Ca2+ Switch Assay
Cells expressing GFP-OclWT and its mutants were grown to confluence in
transwells or 60 mm culture plates. The principle involved in Ca2+ switch assay is
represented in the schematic (Figure 2-2). LCM was prepared from Ca2+ free DMEM
(Thermo Fisher Scientific, Tustin, CA.) supplemented with 1 mM Sodium pyruvate, 2
mM glutamine, 5% dialyzed fetal bovine serum and 10 µM calcium chloride. Barrier
function was monitored by incubating cells in LCM for 16-24 hr. TER and inulin-flux
were measured in transwells at time points ranging from 1 to 24 hr. The media was then
switched with complete media containing NCM and barrier function was monitored for 2
hr. Live-cell imaging of GFP was performed in confluent monolayers in 60 mm dishes.
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Figure 2-2.

Ca2+ Switch Assay.

Ca2+ switch technique is used to study de novo assembly and disassembly of TJ.
Confluent cell monolayers are incubated in Ca2+ depleted media to induce TJ
disassembly. Then the low calcium media (LCM) is switched with normal calcium media
(NCM) to induce TJ assembly. TJ integrity is monitored by measuring TER, flux and
imaging.
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Recombinant GST-Ocl-C Expression
Transformation
The C-terminal region of human occludin encoding the amino acid sequence from
378-522 (Ocl-C) was amplified from the pEGFP-Occludin vector. The amplicon was then
cloned into pGEX-2T vector (Amersham, Arlington Heights, IL). Recombinant Ocl-C
was produced as GST fusion protein (GST-Ocl-C) by transformation of the construct in
E. coli BL21cells. Glycerol stocks were prepared and stored at -80°C.
Culture Scale-up
The culture from glycerol stock was streaked on agar containing ampicillin (Amp;
50ug/ml). The resistant colony was inoculated in 2ml LB-broth and incubated at 37°C
and 250 rpm for 6-8hr. This 2ml culture was then transferred to 100ml LB+Amp and
incubated at 37°C and 250 rpm overnight. The culture was then inoculated into 400ml
LB+Amp and incubated at 37°C and 250 rpm. After 2 hr, 500ul or 0.5 ml of 1M IPTG
(1mM) was added to the 500ml culture and incubated for another 4.5 hr. The culture was
centrifuged at 3500rpm for 30min at 4°C. The supernatant was discarded and the pellet
was stored at -80°C.
Protein Extraction
The pellet was resuspended thoroughly in 15ml lysis buffer (50mM Tris, 1mM
EDTA, 10% Sucrose, pH 7.3) containing protease inhibitor cocktail 10ul/ml each of
PMSF, NaF, Na3VO4. 1.5ml lysozyme (10mg/ml) was added and incubated with rotation
at 4°C for 30min. 0.75ml of freshly prepared 10% NP40 (IGEPAL) detergent was added
and incubated further on the rotator for another 30 min at 4°C. The Lysate was sonicated
to a uniform suspension setting 15 with 1-second strokes (30 strokes). The suspension
was then centrifuged at 12000rpm (20,000g) for 1hr and supernatant was collected.
Protein Purification
750ul of GSH agarose (Sigma) beads (per 15ml supernatant) was prewashed with
cold PBS-IF three times by centrifuging at 13500rpm for 2 min at 4°C. The beads were
added to the extracted supernatant and incubated for 2hr on the rotator at 4°C. After the
incubation, the beads were collected by centrifuging at 13500rpm for 10min at 4°C. The
beads were washed 5 times with cold PBS. Then 1ml of reduced glutathione (20mM) was
added to the beads and incubated for 5min on the rotator. Supernatant was collected by
centrifuging at 2000rpm for 1min at 4°C.
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Dialysis
Supernatant was injected into dialysis cassette (3500 MWCO) and immersed with
a floater in dialysis buffer (50mM Tris, 150mM NaCl, 0.5mM EGTA, 0.05% beta
mercaptoethanol). Buffer was changed every 2 hours, 3 times and then left overnight.
Protein was estimated in the dialyzed sample.
Occludin Regulatory Peptide (ORP)
ORP Characteristics
Occludin regulatory peptide (ORP) was custom synthesized by Biomatik. ORP
comprises of amino acid sequence analogous to ORM (Mol.wt 458193) with a biotin tag
at its N-terminus and a TAT sequence at its C-terminus. The molecular formula of ORP
is C189H290N63O67S2. A stock solution of 1mM ORP in water was prepared for the
experiments. Peptide with scrambled sequence was used as control referred to as ORPscr.
ORP Permeability Studies
•

Caco-2 cell monolayers were grown to confluence on transwells. Cells were
treated with 3µM and 10µM ORP and incubated at 37 °C for 30 min. The
monolayers were fixed and probed with Cy3 conjugated Streptavidin. Fluorescent
images were collected by confocal microscopy.

•

Intestinal sacs from C57BL/6 mice were prepared. One end of the intestinal
segment was sutured and 10µM peptide solution containing FITC-inulin
(0.5mg/ml) was injected from the other end. This end was then sutured to form a
sac. The sacs were incubated in DMEM at 37 °C for 1hr. Cryosections were
prepared and immunostained for ZO-1, biotin and nucleus.

Ca2+ Switch Assay in Presence of ORP
Caco-2 cells were seeded on transwells and allowed to become confluent. Cells
were exposed to DMEM containing 4mM EGTA for 20 min. Following EGTA treatment
media was replaced with DMEM containing 10µM ORP and FITC-inulin (0.5mg/ml).
TER and inulin flux were measured every hour up to 6 hours during recovery. Cell
monolayers were fixed in acetone: methanol mixture and immunostained for occludin
and ZO-1.
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Irradiation in Presence of ORP
Confluent monolayers of Caco-2 cells in transwells were exposed to radiation
(4Gy) and barrier function was compared to the sham treated control. Following radiation
FITC-inulin was added to the media and flux and TER were measured every hour up to 5
hr. Next, the cell monolayers were pre-incubated with 10µM ORP for 30 min and then
exposed to radiation. Following radiation, FITC-inulin was added and barrier function
was assessed by measuring TER and inulin flux. The cell monolayers were fixed and
immunostained for occludin, ZO-1 and nucleus.
ORP Pull Down Assay
ORP Phosphorylation
•

ATP working solution was prepared in Mg buffer containing 20mM MOPS,
25mM β-glycerophosphate, 750 mM MgCl2, 5 mM EDTA, 1 mM vanadate and
1mM DTT.

•

To induce tyrosine phosphorylation, ORP (1mM) was incubated with 0.5ug active
c-Src in tyrosine kinase buffer (50 mm Hepes, pH 7.4, 1 mm EDTA, 0.2% βmercaptoethanol, 3 mm MgCl2) containing 100 µm ATP at 30 °C for 3 hr on a
thermo mixer. Control reactions were performed in the absence of ATP.

•

To induce threonine phosphorylation, ORP (1mM) was incubated with 0.5ug
casein kinase-2 (CK-2) in threonine kinase buffer (80 mM MOPS/NaOH (pH 7.0)
containing 2 mM EDTA) containing 100 µm ATP at 30 °C for 3 hr on a thermo
mixer. Control reactions were performed in the absence of ATP.

•

ORP was trypsin digested to remove TAT sequence. Trypsin stock solution of
200 µg/ml was prepared by dissolving 20 µg of lyophilized trypsin in 100 µl of
resuspension buffer (50 mM acetic acid). Trypsin stock was diluted 1 in 5 in
112.5 mM NH4HCO3 to prepare the working solution. This working solution was
then incubated for 15 min at 37°C. ORP was incubated with equal volume of
working trypsin solution for 3 hours at 37°C and mixed with TPCK solution after
incubation. This ORP was now used as non-phosphorylated control.

ORP Pull Down
Caco-2 cells in T75 flask were grown to confluence. Cells were washed in icecold PBS and extracted in lysis buffer (0.2% Triton X-100 in PBS containing 10 mM
sodium fluoride, 1mM sodium pyrophosphate, 1 mM sodium ortho vanadate, 1mM
PMSF and protease inhibitor cocktail (10 µl/ml). 1ml of extract was added to each of the
non-phosphorylated, tyrosine phosphorylated and threonine phosphorylated ORP
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triplicates. These mixtures were then incubated overnight at 4°C on rocker. 50 µl of
streptavidin-Agarose (prewashed in cold PBS) was added to each sample and incubated
for 1 hour at 4°C on rocker. The beads were centrifuged, washed and subjected to LCMS/MS analysis.
LC-MS/MS Analysis
Sample Workup
Sample bead pellets (3) were suspended in 100 µl Tris-HCl (500 mM, pH 8.5),
CaCl2 (100 mM). The samples were centrifuged for 2 minutes at 10,000 x g and the
supernatant was recovered. This process was repeated one more time. The combined
supernatant was treated with 5 µl of the reducing reagent dithiothreitol (DTT, 1 M in
dH2O) and incubated at 37 oC for 30 min. The reduced samples were incubated with 5 µl
of the cysteine alkylating reagent iodoacetamide (IAA, 2.2 M in dH2O) for 15 min at
room temperature, in the dark. After alkylation, a second aliquot of DTT was added (5 µl,
1 M in dH2O) to neutralize excess IAA.
Following reduction and alkylation, 5 µl of sequencing grade trypsin (1 µg/µl)
were added and the samples were digested at 37 oC overnight. After digestion each
sample volume was reduced by speed vacuum centrifugation to about 20 µl. Trypsin was
neutralized by addition of 3 µl of neat trifluoro acetic acid (TFA). The peptides were
purified with ZipTip C18 (Millipore) using procedures recommended by the
manufacturer. The peptides bound to the C18 column were eluted with 4 µL of 50%
acetonitrile/50% water/0.1% TFA. Two ZipTips per sample were used, and elution was
performed with the same 4 µL-aliquot. After purification, the samples were diluted with 8
µL of water/0.5% formic acid.
LC-MS/MS
The LC-MS/MS analyses were performed with an LTQ linear ion trap mass
spectrometer (Thermo Scientific) interfaced with a Famos/Ultimate nanoflow LC system
(Dionex). Two microliters of peptide digests were manually injected onto a nano injector.
Peptides were separated on a home-packed capillary column (100 mm × 75 µm I.D.)
packed with reversed phase C18 silica (5 µm, 200 Å). The peptides were eluted at a flow
rate of 300 nL/min with a 95 min linear gradient from solvent A
[(H2O:CH3OH:HCOOH), (97.9:2:0.1), v:v:v] to solvent B [(H2O:CH3OH:HCOOH),
(9.9:90:0.1), v:v:v]. The mass spectrometer was operated in a data-dependent scan mode,
where a survey MS scan (400–2000 m/z) was followed by MS/MS of the seven most
intense precursor ions with dynamic exclusion on.
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Peptide Data Analysis
The raw data were input into Proteome Discoverer version 1.4 and searched with
Sequest HT against a human database in silico digested with trypsin. The search
parameters were: full tryptic specificity, precursor error tolerance 1.5 Da, product ion
tolerance 0.8 Da. Allowed peptide modifications were carbamidomethylation of cysteine
(static modification), and methionine oxidation and lysine acetylation (dynamic
modifications). To calculate the false discovery rate for matched peptides, the same rat
reversed database was used as a decoy and the resulting data were statistically analyzed
by Percolator, a new standard component of Proteome Discoverer. Only peptides with
PEP scores of 0.01 or lower were considered as positive matches.
Protein Differential Expression Analysis
The data from the Proteome Discover search results were further analyzed with
the Scaffold software. Scaffold performs advanced processing of MS/MS data, spectral
counting, and comprehensive data management. Scaffold uses statistical algorithms to
validate search results and accepts peptide and protein identifications established at ≥95%
probability. T-test statistics was used to identify differentially expressed proteins (p ≤
0.05).
ORP and GST-Ocl-C Pull Down for MAP7
ORP/ORPscr Tyrosine Phosphorylation
ORP and ORPscr (0.5mM) were incubated with 0.5ug active c-Src in tyrosine
kinase buffer (50 mm HEPES, pH 7.4, 1 mm EDTA, 0.2% β-mercaptoethanol, 3 mm
MgCl2) containing 100 µm ATP at 30 °C for 3 hr on a shaking incubator. These samples
were referred to as pY(tyrosine phosphorylated) forms of ORP and ORPscr. Samples
from similar reactions performed in the absence of ATP were referred to as NP (nonphosphorylated) forms of ORP and ORPscr.
GST-Ocl-C/GST Tyrosine Phosphorylation
Recombinant GST-Ocl-C (20 µg) and equimolar amount of GST (~10 µg) were
incubated with 0.5ug active c-Src in tyrosine kinase buffer (50 mm Hepes, pH 7.4, 1 mm
EDTA, 0.2% β-mercaptoethanol, 3 mm MgCl2) containing 100 µm ATP at 30 °C for 3 hr
on a shaking incubator. These samples were referred to as pY (tyrosine phosphorylated)
forms of GST-Ocl-C and GST. Samples from similar reactions performed in the absence
of ATP were referred to as NP (non-phosphorylated) forms of GST-Ocl-C and GST.
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Pull Down
Caco-2 cell extracts were prepared in lysis buffer (0.2% Triton X-100 in PBS
containing 10 mM sodium fluoride, 1mM sodium pyrophosphate, 1 mM sodium ortho
vanadate, 1mM PMSF and protease inhibitor cocktail (10 µl/ml). ORP-NP, ORP-pY,
ORPscr-NP, ORPscr-pY, GST-Ocl-C-NP, GST-Ocl-C-pY, GST-NP, GST-pY were
incubated with 1ml of cell extract overnight at 4 °C on a n inverter. 30 µl of pre-washed
streptavidin agarose or GSH-agarose beads were added to each sample and incubated at 4
°C for 1 hr. The beads were collected by centrifugation, washed and mixed with sample
buffer. The beads were heated at 100 °C for 10 min and supernatant was collected by
centrifugation. The samples were run on 7% tris-acetate gel and immunoblotted for
MAP-7.
Co-immunoprecipitation: Occludin/MAP7
Caco-2 cell monolayers in 60 mm culture dishes were treated with 3% DSS or
0.35M mannitol in DMEM for 3 hr. The cells were washed with ice-cold PBS and
proteins were extracted in the IP buffer (50 mM Tris buffer, pH 7.4, containing 1%
NP40, 2 mM EDTA, 2 mM EGTA, 10 mM sodium fluoride, 1 mM vanadate and protease
inhibitor cocktail(10 µg/ml)). Protein concentration was estimated by BCA method. 1mg
protein lysates were incubated with 2 µg monoclonal anti-occludin antibody at 4°C
overnight on an inverter. Immune complexes were collected by precipitation using
protein-A/G plus agarose beads and incubation at 4°C for 1hr. The beads were pelleted,
washed, resuspended in sample buffer and heated at 100°C for 10 min to extract the
bound protein. Samples were run on 7% tris acetate gel and immunoblotted for MAP-7.
Colocalization Analysis: Occludin/MAP7
Animal studies were performed according to an IACUC approved protocol.
C57BL/6 mice (12 weeks old) were subjected to radiation (4 Gy). 2 hr post radiation,
colon was harvested from the mice. Cryosections of the colon were prepared and fixed in
acetone:methanol mixture. The fixed tissue sections were immunostained for occludin
and MAP-7. Images were collected by confocal microscopy.
Sources of Materials
Antibodies
Rabbit polyclonal anti-ZO-1, mouse monoclonal anti-occludin & anti-claudin 2,
Alexa Fluor 488-conjugated anti-mouse IgG & phalloidin were purchased from
Invitrogen (Carlsbad, CA). Mouse monoclonal anti-GFP antibody was purchased from
Clontech (Mountain view, CA). Hoechst 33342 were obtained from Life technologies
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(Carlsbad, CA). Mouse monoclonal anti-E-Cadherin and rabbit polyclonal anti-b-catenin
were purchased from BD Biosciences (San Jose, CA). Rabbit polyclonal anti-MAP7,
anti-plakophilin-3, rabbit monoclonal anti-peroxiredoxin 1 and mouse monoclonal antiHSP60 were obtained from EMD Millipore (Bedford, MA). Cy3-conjugated anti-rabbit
IgG, HRP-conjugated anti-mouse IgG, HRP-conjugated anti-rabbit IgG, and mouse antiβ-actin antibodies were obtained from Sigma (St Louis, MO). GFP-Trap_A was
purchased from Chromotek (Hauppauge, NY). Restriction enzymes, T4 DNA ligase,
polynucleotide kinase and DPn1 were obtained from New England Biolabs (Beverly,
MA).
Chemicals
Dulbecco’s minimum essential media (DMEM), fetal bovine serum (FBS) and
antibiotics were purchased from Cellgro (Manassas, VA) while Calcium free DMEM
was from Thermo Fisher Scientific (Tustin, CA.). Cytochalasin-D and genistein were
obtained from Sigma Aldrich (St. Louis, MO). FITC-inulin, protease inhibitor cocktail,
phenylmethylsulfonyl fluoride, Triton-X-100, streptavidin-agarose, GSH-agarose and
IPTG were purchased from Sigma (St. Louis, MO). Protein A/G plus beads were
obtained from Santa Cruz (Dallas, TX). All other chemicals were purchased from Sigma
or Fisher.
Statistical Analysis
All data are expressed as Mean ± SEM. The differences among multiple groups
were first analyzed by ANOVA. When a statistical significance was detected, Tukey's t
test was used to determine the statistical significance between multiple testing groups and
the corresponding control. Statistical significance was established at 95%.
Data containing confocal images was collected from experiments repeated at least
three times. Images were collected from at least three different locations of a stained
monolayer and the best representative image was selected for the figures. Fluorescence
intensity at the intercellular junctions was quantitated using Image J by selecting 20
random ROIs from one image. Statistical analysis was performed by using ANOVA.
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CHAPTER 3.

RESULTS

Specific Aim 1: To Determine That ORM Confers Dynamics to TJ in a
Phosphorylation-dependent Mechanism
Generation of OclDM
It is evident from a significant body of literature that ORM is an active site for
phosphorylation. In order to determine the functional significance of ORM and occludin
in TJ dynamics and regulation, a deletion mutant of occludin that lacks ORM was
generated in a pEGFP plasmid containing human occludin gene (Figure 3-1A).
Restriction digestion, PCR amplification and DNA sequencing confirmed the deletion of
ORM (Figure 3-1B).
Although ORM corresponds to 11 amino acids (Y398-S408), a larger deletion
was designed to include the highly conserved region on either side of ORM (Figure 31C). This resulted in a truncated occludin (OclDM), which lacks 28 amino acids (G388D415) compared to OclWT (Figure 3-1D). The ultimate goal was to perform truncation
analysis of ORM to identify the residues that are essential enough to confer dynamic
properties to TJ and occludin itself.
Deletion of ORM Does Not Prevent Occludin Assembly at the TJ
C-terminus of occludin is known to be required for the assembly and function of
TJ barrier (82). First we examined whether ORM is required for occludin localization at
TJ. To avoid potential interactions with endogenous occludin, occludin-deficient MDCK
(OD-MDCK) cells were used. Stable clones expressing GFP-OclWT, GFP-OclDM or
vector were generated and live imaging was performed to visualize GFP. At least 12
clones were screened for fluorescence, of which 6 are reported here.
In OclDM cells, GFP-occludin was localized at the TJ similar to that in OclWT
cells, where as GFP was intracellular in vector-transfected cells (Figure 3-2A). There
was no clonal difference as occludin localization was similar in all the clones screened
(Figure 3-2B). This suggested that ORM is not required for occludin assembly at TJ.
Absence of ORM in Occludin Does Not Prevent Its Interaction with ZO-1
Occludin C-terminus comprises of a coiled-coil domain that interacts with ZO-1
and this interaction is believed to be required for localization of occludin at TJ (18). First
the expression of mutant occludin versus wild type was examined. Total protein was
immunoblotted for occludin and GFP. Then to look at occludin/ZO-1 interaction, GFP
was immunoprecipitated and immune complexes were blotted for ZO-1 and GFP.
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Figure 3-1.

Occludin Deletion Mutant That Lacks ORM (OclDM).

A. pEGFP construct comprising of human occludin gene. ORM is located in the distal
part of the sequence (Red). B. Double digestion of wild type and mutant constructs with
BstXI and HpaI resulted in two fragments. The smaller fragment in case of mutant
construct had a molecular weight lower than that in wild type construct confirming
deletion of ORM. C. PCR amplification of the nucleotide sequence including ORM
further confirmed the deletion of ORM. D. Schematic showing the location of ORM in
occludin and the amino acid sequence of ORM. E. ORM deletion resulted in OclDM
lacking the amino acid sequence from 388 to 415.
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Figure 3-2.

ORM Deletion Does Not Prevent Assembly of Occludin into TJ.

A: OclWT, OclDM and Vec cell monolayers were imaged live for GFP fluorescence by
confocal microscopy. B: Six clones of OclWT and OclDM cell monolayers were imaged
live for GFP fluorescence using a 40X objective by epi-fluorescence microscopy.
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Immunoblot for occludin showed the knockdown of endogenous occludin in all the
clones. Immunoblot for GFP showed that GFP-OclDM has a molecular weight lower than
GFP-OclWT, confirming the deletion (Figure 3-3A). Immunoprecipitation of GFP
showed that GFP-OclDM interacts with occludin similar to wild type (Figure 3-3B) and
the densitometry confirmed no significant difference in the amount of occludin pulled
down with GFP (Figure 3-3C). This suggested that ORM is not required for interaction
between occludin and ZO-1.
Lack of Both ORM and Occludin Decreases Steady-state Resistance but Does Not
Affect Leak Pathway Permeability
To assess the effect of ORM deletion on barrier function, post-seeding barrier
development was monitored by seeding cells on transwells. TER and unidirectional flux
of FITC-inulin was measured everyday up to 4 days.
Vector transfected cells developed low resistance on day-1, which did not change
even after 4 days post-seeding. Re-expression of wild type occludin (OclWT) in OD cells
increased steady state resistance from day-1 to day-4. However, the expression of mutant
occludin showed no increase in TER (Figure 3-4A). On the other hand, although there
was an initial difference in inulin-flux on day-1 & 2, inulin permeability was similar
among these cells by day-4 (Figure 3-4B). This significant difference in TER with no
apparent change in inulin flux that represents leak pathway, suggested that the
permeability of ions or solutes smaller than inulin was altered in the absence of either
ORM or occludin itself.
Lack of ORM or Occludin Enhances Claudin-2 Expression at the TJ
To explain the differences in TER, we looked at the expression and distribution of
claudin-2 which is a major cationic pore forming claudin (25). Confluent cell monolayers
were fixed in acetone/methanol mixture and immunostained for claudin-2. Total protein
extracts from the cells were immunoblotted for claudin-2.
A significant increase in claudin-2 localization at TJ was seen in cells expressing
OclDM compared to that in OclWT cells (Figure 3-5A). This increase in claudin-2 was
much more prominent in the absence of occludin as confirmed by a measure of claudin-2
fluorescence intensity at the TJ (Figure 3-5B). The immuoblot for claudin-2 showed an
increase in claudin-2 expression in the absence of both ORM and occludin compared to
wild type (Figure 3-5C) that was confirmed by densitometry (Figure 3-5D). These data
support the observation that occludin plays a role in pore pathway permeability by
regulating claudin-2 expression.
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Figure 3-3.

ORM Deletion in Occludin Does Not Prevent Interaction with ZO-1.

A: Total protein extracts from OclWT, OclDM and Vec cells were immunoblotted for GFP,
occludin and β-actin. B: GFP was immunoprecipitated from the native extracts of OclWT,
OclDM and Vec cells and immunoblotted for ZO-1. C: Density of ZO-1 was measured and
normalized to corresponding GFP band density. Values presented in the graph are mean ±
sem (n = 3). Asterisk indicates that the value is significantly (p<0.05) different from
corresponding OclWT value.

Figure 3-4.

ORM Deletion Decreases Steady-state Resistance of the Barrier.

A & B: Equal number of OclWT, OclDM and Vec cells were seeded onto transwell inserts.
TER (A) and FITC-inulin flux (B) were measured at varying post-seeding times. Values
presented in the graph are mean ± sem (n = 6). Asterisks indicate the values that are
significantly (p<0.05) different from corresponding values for OclWT group.
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Figure 3-5.
TJ.

Absence of Occludin or ORM Enhances Claudin-2 Localization at

A & B: Fixed cell monolayers of OclWT, OclDM and Vec were immunostained for
claudin-2 (green) (A) and fluorescence intensity at intercellular junctions was quantitated
(B). C & D: Protein extracts were immunoblotted for claudin-2 and β-actin (C). Density
of claudin-2 was measured and normalized to β-actin band density (D). Values presented
in the graph are mean ± sem (n = 3). Asterisk indicates that the value is significantly
(p<0.05) different from corresponding OclWT value.
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Lack of Both ORM and Occludin Enhances Cytoskeletal Organization and
Occludin Localization at TJ
A non-ionic detergent based protein extraction is widely used to examine the shift
of TJ components between the insoluble and soluble fractions during TJ assembly or
disassembly. Most of the TJ components are pulled down along with the actin
cytoskeleton-rich insoluble fraction. Since the mutant occludin appeared to be distinctly
localized at TJ, we investigated whether there was any difference in the amount of
occludin localization at TJ.
The cells monolayers from day 1 and 3 post-seeding were fixed in 3%
paraformaldehyde and double-labeled for actin and tubulin. Lysates from confluent cell
monolayers were subjected to triton X-100 based lysis and centrifuged to isolate
supernatant, which is referred to as Triton-soluble fraction. The pellet was resuspended
and sonicated to obtain actin -rich fraction referred to as Triton-insoluble fraction. The
lysates were immunoblotted for GFP and actin.
Confocal microscopy showed that actin cytoskeleton was better organized at the
intercellular junctions of OclDM and Vec cell monolayers compared to that in OclWT cell
monolayers on day1. By day 3, cytoskeleton in OclWT appeared to have become well
organized (Figure 3-6A). This suggested that the absence of either ORM or occludin
enhanced cytoskeletal arrangement during barrier development. Immunoblot analysis of
Triton-insoluble and soluble fractions indicated that both GFP- OclWT and GFP- OclDM
were distributed in both fractions. In the triton-soluble fraction there was no significant
difference in the amount of occludin in OclWT versus OclDM cells. However, in the tritoninsoluble fraction, the amount of occludin in OclDM cells was significantly higher
compared to that in OclWT cells. Vector transfected cells that lack occludin acted as a
negative control (Figure 3-6B). The densitometric analysis confirmed that GFP- OclDM
association with the Triton-insoluble fraction was significantly higher that that of GFPOclWT (Figure 3-6C). This indicated that absence of ORM enhanced occludin association
with actin rich fraction of cells.
Deletion of ORM Reduces Occludin Mobility at the Intercellular Junctions
Because occludin localization at TJ was enhanced in ORM deletion mutant cells,
we examined whether there was any difference in occludin mobility in the absence of
ORM. Cells were grown to confluence and FRAP analysis was performed on day 3.
Selected regions of interest (ROI) were defined at the intercellular junctions, bleached
with laser at maximum power at 488nm. The module was set to capture images before
and after the bleach. Fluorescence recovery was quantitated from the time series images
and mobile fraction was calculated.
The time series images showed that the GFP-occludin fluorescence in OclWT cells
recovered faster than that in OclDM cells (Figure 3-7A). Percent recovery fluorescence of
OclDM was significantly lower than that of OclWT (Figure 3-7B). The mobile fraction of
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Figure 3-6. Deletion of ORM Enhances Association of Occludin with Actin-rich
Fraction of Cells.
A: Two days after seeding OclWT, OclDM and Vec cells were fixed and stained for F-actin
(Green), β-tubulin (MT) (Red) and nucleus (Blue). B & C: Triton-soluble and insoluble
fractions prepared from OclWT, OclDM and Vec cells were immunoblotted for GFP and βactin (B). GFP band densities were measured and normalized to corresponding β-actin
band densities (C). Values are mean ± sem (n = 3). Asterisks indicate the values that are
significantly (P<0.05) different from corresponding value for OclWT cells.
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Figure 3-7.

ORM Deletion Reduced Mobile Fraction of Occludin.

A & B: FRAP analysis of GFP in OclWT and OclDM cell monolayers. Time-lapsed images
of ROI (region of interest) at intercellular junctions were collected before and after photo
bleaching (A). Fluorescence intensity in the ROI was measured and plotted against time
(B). Asterisks indicate the values that are significantly (P<0.05) different from
corresponding value for OclWT cells. Percent mobile fractions of OclWT & OclDM were
calculated (C). Values are mean ± sem (n = 8). Asterisk indicates the value that is
significantly (P<0.05) different from corresponding value for OclWT cells.
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deletion mutant occludin significantly reduced compared to the wild type (Figure 3-7C).
This indicated that ORM is required for the mobility of occludin and that its ability to
exchange with the non-tight junction pools is reduced in the absence of ORM.
ORM Deletion Confers Resistance to Ca2+ Depletion-mediated Occludin
Disassembly
In order to investigate the effect of ORM deletion on TJ dynamics, we performed
Ca2+ switch assay in wild type and deletion mutant clones to look at the differences in TJ
disassembly/ assembly. Confluent monolayers of clones expressing GFP-OclWT and
GFP-OclDM were incubated in low calcium media (LCM) for 16 hr. Live images for GFP
were captured before and after the incubation, by confocal microscopy.
OclWT cells showed disassembly of wild type occludin from TJ as expected during
Ca2+ depletion. Interestingly, deletion mutant occludin was not redistributed from TJ in
OclDM cells (Figure 3-8). This resistance was evident in other clones as well, suggesting
that ORM is required for mediating Ca2+ depletion-mediated occludin disassembly from
TJ.
ORM Deletion Confers Resistance to Ca2+ Depletion-mediated Barrier Dysfunction
Ca2+ switch assay in cell monolayers grown on transwells is an important tool to
understand barrier function during de novo TJ assembly and disassembly. Extracellular
Ca2+ depletion induces TJ disruption, decrease in resistance and increase in permeability
while Ca2+ restoration induces TJ assembly, increase in resistance and decrease in
permeability. Here we assessed the effect of ORM deletion on barrier function during
Ca2+ switch. Basal TER and inulin flux were recorded in cell monolayers in regular
media (NCM). Cells were then incubated in LCM for 16 hr and resistance and flux of
inulin was recorded. LCM was switched with NCM and barrier formation was monitored
by measuring TER and inulin flux.
In OclWT cells, Ca2+ depletion-induced a decrease in TER and increase in inulin
permeability, which returned to basal levels after Ca2+ restoration. However, in OclDM
cells that lack ORM, and in Vec cells that lack occludin, there was no significant
difference in TER (Figure 3-9A) and inulin flux (Figure 3-9B) after Ca2+ depletion
compared to their basal values. This further confirmed that ORM is required for Ca2+
depletion-mediated barrier dysfunction.
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Figure 3-8.

ORM Deletion Attenuates Ca2+ Depletion-mediated Occudin Disassembly.

Cell monolayers of OclWT and OclDM clones were incubated with LCM or NCM for 16 hours. Live-cell images for GFP fluorescence
were collected before and after incubation by confocal microscopy.
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Figure 3-9. ORM Deletion Attenuates Ca2+ Depletion-induced Barrier
Dysfunction.
A & B: OclWT and OclDM cell monolayers on transwell inserts were incubated with LCM
for 16 hours followed by incubation with NCM for up to 3 hr. TER (A) and FITC-inulin
flux (B) were measured at varying times. Values are mean ± sem (n = 6). Asterisks
indicate the values for OclWT cell monolayers that are significantly (p<0.05) different
from corresponding values for OclDM and Vec cell monolayers.
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Deletion of ORM Confers Resistance to Disruption of Apical Junctional Complex
and Cytoskeleton
Tight junctions and adherens junctions form key components of the apical
junctional complex that are directly or indirectly connected to the actin cytoskeleton via
scaffold proteins proteins and actin linkers. Here we examined the effect of ORM
deletion on Ca2+ depletion-mediated changes in the apical junctional complex. Confluent
cell monolayers were incubated in LCM and fixed in 3% paraformaldehyde. The fixed
monolayers were labeled for TJ components: GFP-occludin and ZO-1, AJ components:
E-cadherin and b-catenin and cytoskeleton: actin and tubulin.
Ca2+ depletion in OD-OclWT cells induced redistribution of occludin and ZO-1
indicating TJ disruption (Figure 3-10A) as well as redistribution of E-Cadherin and bcatenin indicating the disruption of AJ (Figure 3-10B). However, OD-OclDM cells were
resistant to both TJ and AJ disruption. Ca2+ depletion also induced disassociation of actin
and tubulin in OclWT but not in OclDM monolayers (Figure 3-10C). These results together
confirmed that ORM is required for mediating Ca2+ depletion-induced disruption of TJ,
AJ and cytoskeleton.
ORM Deletion Attenuates TJ and AJ Disruption Induced by EGTA-based Ca2+
Depletion
EGTA is a Ca2+ chelating agent widely used to deplete extracellular Ca2+ in
calcium switch assay. Because OclDM cells were resistant to low Ca2+-mediated TJ
disruption, we used EGTA to induce TJ disassembly. Confluent cell monolayers were
exposed to 4mM EGTA and TER and inulin-flux were measured at varying time points.
Fixed monolayers were labeled for GFP, ZO-1, E-cadherin and β-catenin. The images
were collected using a confocal microscope.
In OclWT cells, EGTA induced a decrease in TER by 5 min, which was delayed in
the case of OclDM cells (Figure 3-11A). EGTA treatment led to an increase in inulin-flux
in cells OclWT cells, which was significantly delayed in OclDM cells (Figure 3-11B).
GFP-occludin and ZO-1 started to show disassembly as early as 5 min, which was
prominent by 30 min. On the other hand, OclDM cells showed significant delay in
occludin disassembly (Figure 3-11C). Similarly differences in AJ redistribution were
observed (Figure 3-11D). These data confirmed that ORM deletion confers resistance to
Ca2+depletion-mediated occludin disassembly.
Deletion of ORM Does Not Prevent CytochalasinD-mediated Disruption of TJ and
Barrier Dysfunction
Disruption of actin cytoskeleton also disrupts TJ. To examine whether the
resistance to TJ disruption in the absence of ORM was specific to Ca2+depletion, here we
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Figure 3-10. ORM Deletion Attenuates Ca2+ Depletion-mediated Disruption of
Apical Junctional Complex and Cytoskeleton.
A, B & C: OclWT and OclDM cell monolayers were incubated with LCM or NCM for 16
hr. Fixed cell monolayers were stained for TJ proteins GFP-occludin (green) and ZO-1
(red) (A), AJ proteins E-cadherin (green) and β-Catenin (red) (B) and cytoskeletal
proteins F-actin (red) and β-tubulin (green) (C).
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Figure 3-11. ORM Deletion Attenuates EGTA-mediated TJ and AJ Disruption.
A & B: OclWT and OclDM cell monolayers on transwell inserts were incubated with 4 mM
EGTA. TER (A) and FITC-inulin flux (B) were measured at varying times. Values are
mean ± sem (n = 6). Asterisks indicate the values for OclWT cell monolayers that are
significantly (p<0.05) different from corresponding values for OclDM and Vec cell
monolayers. C & D: Cell monolayers fixed at varying times after EGTA administration
were co-stained for GFP (Green) & ZO-1 (Red) (C) or E-cadherin (Green) & β-catenin
(Red) (D).
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employed another method to disrupt TJ. Confluent cell monolayers in transwells were
treated with cytochalasin D (2 µg/ml ). Barrier function was assessed by measuring TER
and inulin flux at various time points. Live imaging was also performed by exposing cells
to cytochalasin D.
Incubation of OclWT, OclDM and Vec cell monolayers with cytochalasin-D resulted
in a drop in TER (Figure 3-12A) and increase in inulin-flux (Figure 3-12B). Live cell
imaging of GFP fluorescence showed that cytochalasin-D induced disruption of occludin
from the junctions in both OclWT and OclDM cell monolayers. All cells displayed
characteristic appearance of discontinuous junctional occludin, typical of cytochalasin-D
induced TJ disruption. These data together suggested that ORM is not required for
mediating cytochalasin-D mediated barrier dysfunction.
Deletion of ORM Does Not Prevent Osmotic Stress-mediated Disruption of TJ and
Barrier Dysfunction
Another method to disrupt TJ was employed to investigate the specificity of
ORM deletion-induced resistance to Ca2+ depletion-mediated TJ disruption. Confluent
cell monolayers in 60 mm dishes and 12 mm transwells were exposed to 600mOsM
DMEM to induce osmotic stress. Barrier dysfunction was monitored by measuring TER
and inulin-flux and live-cell imaging for GFP at varying time points. Fixed monolayers
were stained for GFP and ZO-1 by immunofluorescence method.
Exposure to osmotic stress induced increase in inulin permeability in OclWT,
Ocl and Vec cell monolayers (Figure 3-13A) Live cell imaging for GFP showed
osmotic stress-mediated junctional redistribution of GFP-occludin in both OclWT and
OclDM cell monolayers (Figure 3-13B). Stain from fixed cell monolayers for GFP and
ZO-1 indicated that osmotic stress induced redistribution of GFP-occludin and ZO-1
from the intercellular junctions in both OclWT and OclDM cell monolayers (Figure 313C).
DM

Phoshorylation of ORM on T403/403 and Y398/402 Determines Dynamic Properties
of Occludin
Previous studies showed that the phosphorylation of threonine residues
(T403/404) enhances TJ assembly while phosphorylation of tyrosine residues (Y398/402)
negatively regulates TJ assembly. To investigate the role of ORM phosphorylation in
occludin dynamics we generated OD-mutant clones expressing GFP-OclT403/404A, GFPOclT403/404D, GFP-OclY398/402A and GFP-OclY398/402D. Confluent cell monolayers were
incubated in LCM and live images were captured at varying time points. FRAP analyses
was performed in these cells to assess the role of ORM phosphorylation on occludin
mobility.
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Figure 3-12. ORM Deletion Does Not Prevent Cytochalasin-mediated TJ
Disruption and Barrier Dysfunction.
A & B: OclWT, OclDM and Vec cell monolayers on transwell inserts were incubated with
Cytochalasin-D. TER (A) and FITC-inulin flux (B) were measured at varying times.
Values are mean ± sem (n = 6). C: Live-cell images for GFP fluorescence were captured
at varying times.
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Figure 3-13. ORM Deletion Does Not Prevent Osmotic Stress-mediated TJ
Disruption and Barrier Dysfunction.
A: OclWT, OclDM and Vec cell monolayers were incubated with hyperosmotic medium
and FITC-inulin flux was measured at varying times. Values are mean ± sem (n = 6). B:
OclWT and OclDM cell monolayers were incubated with hyperosmotic medium (0.35M
mannitol) and live images for GFP fluorescence were captured at varying times. C: Fixed
cell monolayers were co-stained for GFP (Green) and ZO-1 (Red).
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Live cell imaging of GFP fluorescence showed that incubation with LCM for 24
hr resulted in redistribution of GFP-OclT403/404D from the intercellular junctions similar to
GFP-OclWT. However, redistribution of GFP-OclT403/404A was not altered with Ca2+
depletion similar to that of GFP-OclDM. On the other hand, incubation with LCM induced
partial redistribution of both GFP-OclY398/402D and GFP-OclY398/402A (Figure 3-14). These
observations indicated that ORM contributes to occludin dynamics in a phosphorylation
dependent mechanism. FRAP analysis demonstrated that the percent mobile fraction of
GFP fluorescence OclT403/404D cell monolayers was similar to that of OclWT, whereas
mobile fractions of OclDM, OclT403/404A, OclY398/402D and OclY398/402A were significantly
low compared to that of OclWT cell monolayers (Figure 3-15).
Phosphorylation of ORM on T403/403 and Y398/402 Determines Dynamic
Properties of TJ
To investigate the role of ORM phosphorylation in TJ dynamics, mutant clones
expressing GFP-OclDM, GFP-OclT403/404A, GFP-OclT403/404D, GFP-OclY398/402A and GFPOclY398/402D and wild type cells expressing GFP-OclWT were grown on transwells.
Confluent cell monolayers were incubated in LCM and barrier function was assessed.
Fixed monolayers at varying time points were labeled for GFP and ZO-1.
Measurement of TER in these cell lines showed that, incubation with LCM for 16
hr results in a decrease in TER in OclWT and OclT403/404D cell monolayers; these effects are
significantly greater compared to those in OclDM, OclT403/404A, OclY398/402D and OclY398/402A
cell monolayers (Figure 3-16A). Inulin flux measurement, after 16 hr incubation with
LCM showed increased inulin permeability in both OclWT and OclT403/404D cell
monolayers. LCM-mediated inulin permeability was low in OclDM and OclT403/404A cell
monolayers and moderate in OclY398/402D and OclY398/402A cell monolayers (Figure 3-16B).
Immunofluorescent staining of fixed monolayers for GFP and ZO-1 showed that LCM
induced redistribution of both occludin and ZO-1 from intercellular junctions in OclWT
and OclT403/404D cell monolayers but not in OclDM and OclT403/404A cell monolayers.
Ca2+ depletion had a significantly low effect on redistribution of occludin and ZO-1 in
both OclY398/402D and OclY398/402A cell monolayers compared to that in OclWT cell
monolayers (Figure 3-17). These data together suggested that ORM confers dynamic
properties to TJ in a phosphorylation dependent mechanism.
Tyrosine Phosphorylation Plays a Role in Ca2+ Depletion-mediated TJ Disruption
Oxidative stress and osmotic stress mediated TJ disruption involves tyrosine
phosphorylation of occludin on residues Y398 and Y402. However, very little is known
about the role of tyrosine phosphorylation in Ca2+ switch assay. From the studies using
mutation of tyrosine residues in ORM, it was clear that tyrosine phosphorylation is also
involved in LCM-mediated TJ disruption. In order to further validate the role of tyrosine
phosphorylation in Ca2+ depletion-mediated TJ disruption, MDCK cells grown on
transwells were pretreated with either genistein or DMSO for 1hr. Cells were incubated
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Figure 3-14. ORM Confers Dynamic Properties to Occludin in a Phosphorylationdependent Manner.
OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and OclY398/402D cell monolayers were
incubated with LCM for 24hr and in NCM for 2 hr. Live-cell images for GFP
fluorescence were collected before and after incubation.
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Figure 3-15. ORM Phosphorylation Determines Mobility of Occludin at TJ.
FRAP analysis of GFP in OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and
OclY398/402D cell monolayers. Time-lapse images were collected before and after photo
bleaching of ROI at intercellular junctions. Fluorescence intensity was measured and %
mobile fraction was calculated.
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Figure 3-16. ORM Determines Barrier Function in a Phosphorylation-dependent
Mechanism.
A & B: OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and OclY398/402D cell
monolayers on transwell inserts were incubated with LCM for 16 hours. TER (A) and
FITC-inulin flux (B) were measured at varying times. Values are mean ± sem (n = 6).
Asterisks indicate the values for OclWT cell monolayers that are significantly (p<0.05)
different from corresponding values for OclDM and Vec cell monolayers.
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Figure 3-17. ORM Confers Dynamic Properties to TJ in a Phosphorylation-dependent Mechanism.
OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and OclY398/402D cell monolayers were incubated with LCM for 16 hr. Cell
monolayers fixed at 1 hr and 16 hr were stained for GFP (Green) and ZO-1 (Red).
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in LCM and barrier function was monitored by measuring TER and inulin-flux. Cell
monolayers fixed at varying time points were labeled for occludin and ZO-1. Incubation
with LCM induced a decrease in TER (Figure 3-18A) and an increase in inulin-flux
within 1 hr (Figure 3-18B), whereas treatment with genistein blocked the effect of LCM.
Confocal images for occludin and ZO-1 showed that LCM induced redistribution of both
occludin and ZO-1 from intercellular junctions into the intracellular compartment
whereas cell monolayers treated with genistein were resistant to LCM-mediated
redistribution of occludin and ZO-1 (Figure 3-18C). These data confirm that tyrosine
phosphorylation plays a significant role in Ca2+ depletion-mediated TJ disruption.
Specific Aim 2: To Determine That ORM-mediated Protein Interactions Are
Involved in TJ Modulation
ORP Permeability
In order to study the role of ORM in TJ modulation, we designed a synthetic
peptide based on the occludin regulatory region. It has a biotin tag at its N-terminus and a
TAT domain at its C-terminus. The biotin tag was intended to aid in the pull down
assays, while the TAT sequence was added to aid in the permeation of ORP into cells.
The peptide design is as shown in (Figure 3-19A). A scrambled peptide was used as a
control.
First we investigated the permeation of ORP in Caco-2 cells. Confluent cell
monolayers were treated with ORP. Fixed cell monolayers were immunostained for
biotin and occludin. We then tested ORP permeability in mouse intestine. Isolated
intestinal loops were injected with either saline or ORP and incubated for 1 hr.
Cryosections were labeled for ZO-1, biotin and nucleus.
The confocal images of Caco-2 cell monolayers showed that ORP does permeate
into the cells in a dose dependent manner, as seen by an increase in the intracellular Cy3streptavidin (Red), stained for biotin (Figure 3-19B). The images of intestinal loop
injected with ORP showed a similar permeation of ORP into intestinal mucosa as seen by
the stain for biotin (Red) (Figure 3-19C). These data together showed that ORP has the
ability to permeate into cells.
ORP Enhances TJ Assembly During Ca2+ Switch Assay in Caco-2 Cells
The biological effect of ORP was examined in Caco-2 cells. Ca2+ switch assay
was performed in confluent cell monolayers in the presence of the peptide. EGTA was
used to deplete extracellular Ca2+ from the media and induce TJ disassembly. During
recovery, ORP was added to normal Ca2+ containing media. Inulin flux was measured at
varying time points. Cell monolayers fixed 1hr after calcium switch were double labeled
for occludin and ZO-1.
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Figure 3-18. Ca2+ Depletion-induced TJ Disruption Involves Tyrosine
Phosphorylation.
A & B: MDCK cell monolayers on transwells were treated with 100 µM genistein. TER
(A) and FITC-inulin flux (B) were measured after 1 hr. C: Cell monolayers treated with
genistein were fixed at 1hr after incubation in LCM and co-stained for GFP (Green) and
ZO-1 (Red).
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Figure 3-19. ORP Sequence and Its Permeability.
A: ORP is comprised has an N-terminal biotin tag and a C-terminal TAT domain.
ScrORP has a scrambled sequence. B: Confluent cell monolayers were treated with 3 µM
and 10 µM ORP. Fixed cell monolayers were immunostained with anti-occludin antibody
and Cy3-conjugated streptavidin. C: Isolated intestinal loops from C57BL/6 mice were
injected with either saline or 10 µM ORP and incubated in DMEM at 370C for 1 hr.
Cryosections of the loops were fixed and immunostained for ZO-1 (green), biotin (red)
and nucleus (blue).
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Ca2+ depletion-induced inulin permeability was seen to decline during Ca2+
switch-mediated recovery, indicating TJ assembly. This decrease in inulin-flux was
enhanced by the presence of ORP in a dose-dependent manner (Figure 3-20A). Confocal
images showed that ORP enhanced junctional assembly of occludin and ZO-1 in ORP
treated monolayers compared to that of the control (Figure 3-20B). These observations
indicated that ORP has the ability to mimic ORM based interactions required for TJ
assembly.
ORP Attenuates Radiation-induced Barrier Dysfunction and TJ Disruption
In order to study the effect of ORP on barrier function, a radiation model was
used. Confluent monolayers of Caco-2 cells in transwells were exposed to radiation (4
Gy). The barrier function post-radiation was monitored by measuring flux of FITC-inulin
and TER.
To examine the effect of ORP on radiation induced barrier dysfunction, cells were
pre-treated with ORP for 30 min and then exposed to radiation. TER and inulin-flux were
measured. Cells were fixed at varying time points and immunostained for occludin, ZO-1
and nucleus.
Radiation induced a significant decrease in TER compared to the sham control
(Figure 3-21A). There was a significant increase in inulin permeability in radiation
treated cells compared to sham control (Figure 3-21B) indicating barrier dysfunction by
radiation. However, when the cells were pre-incubated with ORP, 30 min prior to
irradiation, barrier dysfunction was significantly attenuated compared to the scrambled
control treatment as seen by relatively less drop in TER (Figure 3-21C) and decreased
inulin flux (Figure 3-21D). The confocal images showed that ORP treatment attenuated
radiation-induced disassembly of occludin and ZO-1 from TJ (Figure 3-22). These data
together suggested that ORP attenuates radiation-induced barrier disruption.
ORP as a Bait
In order to identify the proteins that interact with ORM, ORP that has a biotin tag
at its N-terminus was used as bait in pull down assays. Incubation of recombinant GST
tagged occludin C-terminus (GST-Ocl-C) with tyrosine kinase led to phosphorylation of
tyrosine residues, as seen by an immunoblot for phospho tyrosine (33,34). Incubation of
GST-Ocl-C with a serine/threonine kinase in vitro led to phosphorylation of threonine
and serine residues and was evident from an immunoblot for phospho threonine and
phospho serine (57).
Similarly, ORP was pre-phosphorylated in vitro by incubation with either active
c-Src or CK2 in presence of ATP to yield tyrosine phosphorylated ORP (ORP-pY) or
threonine-phosphorylated ORP (ORP-pS/T) respectively. These phosphopeptides were
incubated with native protein extracts from Caco-2 cells and biotin was pulled down
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Figure 3-20. ORP Enhances TJ Assembly.
Caco-2 cells seeded on transwells were treated with 4 mM EGTA. Following this, the
media was switched with regular media containing either 3 & 10 µM ORP or scrambled
control along with FITC-inulin (0.5 mg/ml). A. Inulin flux was measured for 6 hr during
recovery. B. The monolayers were fixed 1 hr after Ca2+ switch and immunostained for
occludin (Green) and ZO-1 (Red).
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Figure 3-21. ORP Attenuates Radiation-induced Barrier Dysfunction.
A & B: Confluent cell monolayers of Caco-2 cells in transwells were exposed to
radiation (4 Gy). TER (A) and inulin-flux (B) were measured at varying time points. C &
D: Cell monolayers were pre-treated with ORP for 30 min and then exposed to radiation
(4 Gy). TER (C) and inulin-flux (D) were measured post-radiation.
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Figure 3-22. ORP Attenuates Radiation-induced TJ Disruption.
Cell monolayers pretreated with 10µM ORP were exposed to radiation (4Gy) and fixed at
2 hr post-radiation. Monolayers were immunostained for occludin (Green), ZO-1 (Red)
and nucleus (Blue).
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using streptavidin agarose. The beads were isolated and subjected to LC-MS/MS
analysis. By a bottom-up proteomics approach, the proteins pulled down in each sample
were identified. Immunoblot analysis was performed for selective proteins.
The proteins identified in each group were statistically analyzed and proteins were
shortlisted based on the statistical scores (Table 3-1). Some proteins were pulled down
by peptide irrespective of its phosphorylation status, like Peroxiredoxin 1 (PRDX1),
where as some proteins pulled down were found exclusively in each group, like
microtubule associated protein (MAP7). These data suggested that proteins interact with
ORM in a phosphorylation-dependent mechanism. The ion spectra profiles of HSPD1,
PRDX1, MAP7 and PKP3 peptides are provided in the figure (Figure 3-23).
Immunoblot analyses was performed for PRDX1, Heat shock protein 60
(HSPD1), Plakophilin 3 (PKP3) and MAP7. This confirmed interaction of native peptide
with HSP 60 and PRDX1. On the other hand, immunoblot for MAP7 and plakophilin 3
showed an enhanced interaction between tyrosine phosphorylated ORP and MAP7 as
well as plakophilin3 (Figure 3-24). These data confirmed that ORP binds to proteins in a
phosphorylation-dependent manner.
MAP7 Binds to Tyrosine-Phosphorylated ORP and GST-Ocl-C
MAP7 is an epithelial specific microtubule associated protein known to be an
essential cofactor for Kinesin-1 driven transport. Microtubule is believed to mediate actomyosin contraction and internalization of TJ proteins form junctions during Ca2+
depletion mediated TJ disruption. In order to validate the interaction between ORM and
MAP7, both ORP and recombinant GST-Ocl-C were used. GST-Ocl-C comprises of the
distal 150 amino acids of the occludin C-terminus. ORP and GST-Ocl-C were prephosphorylated with c-Src in presence or absence of ATP and used as baits for the pull
down assay using either streptavidin agarose or GSH agarose beads. ORPscr and GST
were used as their respective controls. The protein complexes were immunoblotted for
MAP7.
MAP7 was pulled down in case of ORP (NP) but not ORPscr. There was a
significant increase in the amount of MAP7 pulled with ORP-pY, indicating that tyrosine
phosphorylation enhances interaction between ORM and MAP7 (Figure 3-25A).
Similarly, MAP7 was pulled down exclusively by GST-Ocl-C-pY (Figure 3-25B),
suggesting that MAP7 interacts with tyrosine phosphorylated occludin C-terminus.
DSS or Osmotic Stress Enhances Interaction Between Occludin and MAP7
In order to validate the interaction between full length occludin and MAP7, coimmunoprecipitation analysis was performed in Caco-2 cells. Previous studies showed
that both DSS and osmotic stress induce tyrosine phosphorylation of occludin (83,84).
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Table 3-1.

ORM-interacting Proteins Identified by LC-MS/MS.
ORP (NP)
(Total Proteins-78)
Peroxiredoxin-1 (PRDX1)
Acetyl CoA acetyltransferase
Protein disulfide-isomerase A6
Heat shock protein (HSPD1)
Protein disisomerase A6
ATP-citrate synthase
Triose phosphate isomerase
Glucose regulated protein
Fatty acid synthase
Thiamine transporter 1

ORP (pY)
(Total Proteins-91)
Ensconsin (MAP7)
Plakophilin-3 (PKP3)
Peroxiredoxin 1 (PRDX1)
RNA helicase
Tubulin beta-4 A
Elongation factor 1a
POU-domain binding protein
Heat shock protein (HSPD1)
Glutathione-S-transferase
Glutathione peroxidase

ORP (pS/T)
(Total Proteins-85)
THO complex subunit 4
Phosphate carrier protein
RNA helicase
Peroxiredoxin-1
RNA binding protein EWS
Glucose regulated protein
Glutathione peroxidase-1
Tubulin beta-4a
Thiamine transporter 1
Heat shock protein (HSPD1)

Note: The table here enlists the statistically significant proteins (p ≤ 0.05) identified in pull down assay using non-phosphorylated
ORP, tyrosine phosphorylated ORP (ORP-pY) and serine/threonine phosphorylated ORP (ORP-pS/T).
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Figure 3-23. Ion Spectra Profiles of Peptides Corresponding to the Proteins
Identified by LC-MS/MS.
Represented here are the ion sprectra profiles of peptides corresponding to peroxiredoxin
1(PRDX1), heat shock protein 60 (HSPD1), microtubule associated protein (MAP7) and
plakophilin 3 (PKP3).
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Figure 3-24. Immunoblot Analyses for Proteins Pulled Down by ORP.
A: ORP or ORPscr in their native form were incubated with native cell extracts and
subjected to pull down using streptavidin agarose. Protein complexes were
immunoblotted for HSP60 and Peroxiredoxin1. B: Peptides were pre-phosphorylated
with active c-Src (ORP-pY or ORPscr) and incubated with native cell extracts for the pull
down. Protein complexes were immunoblotted for MAP7 and Plakophilin3.

Figure 3-25. MAP7 Interacts with Tyrosine-phosphorylated ORP and Occludin Cterminus.
A & B: ORP and ORPscr (A) or GST and GST-Ocl-C (B) in their native form or prephosphorylated with active-Src were incubated with Caco-2 cell extracts. Protein
complexes were immunoblotted for MAP7 and GST.
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Caco-2 cells were treated with either 3% DSS or osmotic stress. MAP7 was
immunoprecipitated from the native cell extracts and immunoblotted for occludin and
MAP7.
The immunoblot showed a minimal interaction between occludin and MAP7 in
controls. However, this interaction was significantly enhanced by both DSS and osmotic
stress (Figure 3-26A). The densitometric analysis confirmed that tyrosine
phosphorylation enhanced interaction between occludin and MAP7 (Figure 3-26B). This
suggested that MAP7 interacts with occludin in a tyrosine phosphorylation dependent
mechanism.
MAP7 Colocalizes with Occludin in Irradiated Mouse Colon
To validate the interaction between MAP7 and occludin in vivo, C57BL/6 mice
were subjected to radiation (4Gy) and intestinal tissues were harvested after 2 hours.
Cryosections of distal colon were fixed and immunostained for occludin and MAP7.
High-resolution images were collected by confocal microscopy.
In the sham treated mouse colon, MAP7 had an intracellular distribution located
near the perijunctional region. No colocalization of occludin and MAP7 was seen in the
absence of radiation. However, MAP7 appeared to colocalize with occludin in irradiated
mouse colon (Figure 3-27). These data suggested that radiation-induced tyrosine
phosphorylation of occludin results in a potential interaction between occludin and
MAP7.

73

Figure 3-26. MAP7 Interacts with Occludin in a Tyrosine phosphorylationdependent Mechanism.
A: MAP7 was immunoprecipitated from cell extracts isolated from Caco-2 cells treated
with either 0.35M mannitol or 3% DSS for 3 hr. Immune-complexes were blotted for
MAP7 and occludin. B: Density of occludin was measured and normalized to
corresponding MAP7 band density. Values presented in the graph are mean ± seem (n =
3). Asterisk indicates that the value is significantly (p<0.05) different from corresponding
control value.
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Figure 3-27. MAP7 Colocalizes with Occludin in Radiation Exposed Mouse Colon.
Mice (C57BL/6) were subjected to radiation (4Gy) and intestinal tissues were harvested 2
hr. post-radiation. Cryosections of distal colon were fixed and labeled for occludin
(Green) and MAP7 (Red). Images were collected by confocal microscopy. Inset shows
zoomed-in regions of colocalization.
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CHAPTER 4.

DISCUSSION

Specific Aim 1: To Determine That ORM Confers Dynamics to TJ in a
Phosphorylation-dependent Mechanism
Occludin is considered as a functional component of TJ. The phosphorylation hot
spot in occludin (ORM) is a potential regulatory platform that mediates phosphorylationdependent regulation of TJ. Several disorders have been shown to involve occludin
redistribution from TJ with the associated increase in permeability and barrier
dysfunction. Hence determining the function of ORM is crucial to understand TJ
modulation both in the aspects of its physiology as well as disease pathogenesis.
ORM Is Not Required for Assembly of Occludin into TJ
Previous studies demonstrated that loss of occludin does not prevent TJ assembly,
in both in vitro and in vivo models (35, 36). The intracellular transport of occludin is
governed by its C-terminus (37). C-terminal sequence of ~150 amino acids (358-504)
was believed to be required for occludin localization at TJ (14). However, Bald et al
showed that C-terminally truncated chicken occludin localized at TJ in MDCK cells,
although with a discontinuous distribution (85). A study by Chen et al using Xenopus
embryos showed that C-terminally truncated mutant chicken occludin localized at TJ by
its ability to oligomerize with endogenous occudin (38). In order to study the function of
ORM, we first generated deletion mutant of occludin (OclDM) that lacks ORM. To avoid
potential interactions with the endogenous occludin, we transfected OclDM into occludin
deficient-MDCK cells and generated stable clones. As ORM is located in the C-terminus
we examined whether the deletion of ORM affected the assembly of occludin into TJ.
Consistent with the previous data, lack of ORM did not affect assembly of OclDM into TJ,
indicating that ORM is not required for TJ assembly.
The association of C-terminal sequence (358-504) with ZO-1 is required for
occludin assembly at TJ (18). Structural analysis revealed that the distal C-terminal
region (416-522) of occludin forms a coiled-coil structure that was sufficient for
interaction with the guanylate kinase domain (GUK) of ZO-1 (31). Because ORM is
located in close proximity with the coiled coil domain, we investigated if the interaction
between occludin and ZO-1 was affected by deletion of ORM. Our studies showed that
ZO-1 co-immunoprecipitated with GFP-OclDM similar to GFP-OclWT. This indicates that
ORM is not required for the interaction between occludin and ZO-1. Based on these
observations we concluded that ORM is not required for occludin assembly into
intercellular junctions.
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ORM Deletion Does Not Affect Barrier Development by Leak Pathway Flux
Expression of both wild type and COOH-terminally truncated chicken occludin in
MDCK cells induced an increase in TER, but only the truncated occludin expression
induced an increase in paracellular permeability (40). Another study demonstrated that
knock down of occludin in MDCK cells altered paracellular ion permeability but not
steady-state TER (86). To determine the effect of ORM deletion on barrier function, post
seeding barrier development was assessed. Similar to OclWT, expression of OclDM showed
a decrease in inulin permeability by day 4, indicating that the absence of ORM does not
affect the barrier development. Interestingly, even on day 4 the resistance of OclDM and
Vec cell monolayers remained lower than that in OclDM cell monolayers, although the
inulin permeability was not different. This observation suggested that the pore pathway
might be affected by ORM deletion, while leak pathway remains unaffected.
TER is a measure of the flux of all ions across the epithelium. Small ions do not
discriminate between pore and leak pathways. A change in TER with unaltered leak
pathway permeability implicated a change in pore pathway permeability. The expression
of a subset of claudins that have the ability to form pores is known to determine
paracellular permeability (87). In order to account for the differences in TER in these
clones, we examined the expression and distribution of claudin-2, a major cationic pore
forming claudin (25). A previous study has shown that S408 phosphorylation of occludin
regulates claudin-2 localization in Caco-2 cell monolayers (27). Immunoblot analysis and
confocal microscopy showed that claudin-2 levels and its junctional distribution were
greater in OclDM and Vec cell monolayers compared to that of OclWT cell monolayers.
Results indicated that the enhanced junctional localization of claudin-2 might have
contributed to lower TER in these cell lines. These data suggest that barrier development
in terms of TJ assembly at intercellular junctions is not affected by ORM deletion,
however TJ regulation-mediated flux through pore pathway is affected in the absence of
ORM. We showed for the first time that ORM might be involved in the regulation of pore
pathway.
ORM Deletion Enhances Occludin Localization and Reduces Its Mobility at the TJ
The actin cytoskeleton is a dynamic network that maintains cellular architecture
and tissue organization. Transmission electron microscopy and immunogold labeling
studies revealed that a perijunctional actomyosin ring is located below the apical
junctional complex (88,89). The cytoplasmic TJ plaque is closely associated with the
cortical cytoskeleton via interactions with the scaffolding protein, ZO-1 (12). Early
studies using pharmacological agents of disruption also revealed that the cytoskeleton
plays an important role in regulating TJ permeability (88). It was implicated that
cytoskeletal organization is important for maintenance of the TJ architecture and hence
their sealing properties. Occludin C-terminus is known to interact with the actomyosin
ring indirectly via its interaction with ZO-1(90). Here we examined the cytoskeletal
organization of cells lacking ORM or occludin, during barrier development and the
distribution of occludin between detergent soluble and detergent insoluble fractions.
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Confocal microscopy showed that actin cytoskeleton was better organized at the
intercellular junctions of OclDM and Vec cell monolayers compared to OclWT cell
monolayers. Immunoblot analysis suggested that lack of ORM enhanced association of
occudin with the actin rich triton insoluble fraction.
Studies by Turner group have established the fact that TJ undergoes continuous
remodeling at steady state. FRAP based studies by Shen et al (6) demonstrated that TJ
proteins are highly dynamic and that they are in constant exchange with extra-junction
pools. It was believed that it is through this plasticity of constant exchange with extrajunction pools, TJ proteins respond to external and internal stimuli involved in
paracellular barrier regulation. Each TJ protein has a distinct dynamic behavior. They
showed that occludin was the most mobile among all the TJ proteins and exchanges by
diffusion within and between TJ and lateral membrane. From our studies, FRAP analysis
of the dynamic behavior of occludin showed that deletion of ORM makes occludin at the
intercellular junctions, more static and less mobile. ORM may be required for this
mobility of occludin. We believe that the increased association of OclDM with the actin
cytoskeleton contributes to the reduced mobility.
ORM Deletion Specifically Attenuates Ca2+ Depletion-mediated Disruption of
Apical Junctional Complexes and Barrier Dysfunction
Ca2+ switch assay is a widely used technique to study de novo assembly of TJ,
however the mechanism involved in Ca2+ depletion-mediated TJ disassembly or Ca2+
repletion-mediated TJ resassembly has not been identified. However, it is believed that
the extracellular Ca2+ depletion-induced AJ disruption, as E-cadherin requires Ca2+ for its
hemophilic interactions, leads to disruption of TJ. Another probable mechanism likely
involved is that the depletion of extracellular Ca2+ leads to a decrease in intracellular
Ca2+, which activates a signaling cascade that disassembles TJ and AJ components.
ORM deletion attenuated Ca2+ depletion-induced TJ, AJ, cytoskeleton disruption and
barrier function.
The lack of an effect of LCM on junctional distribution of GFP-OclDM suggested
that ORM is required for Ca2+ depletion -mediated redistribution of occludin. The lack of
an effect of LCM on junctional distribution of ZO-1 in OclDM cell monolayers indicates
that absence of ORM prevents disruption of TJ by Ca2+ depletion. Sustained junctional
organization of E-cadherin and b-catenin in LCM-treated OclDM cell monolayers suggests
that ORM deletion prevents disruption of AJ by Ca2+ depletion. Stability of actin
cytoskeleton and microtubules in LCM treated OclDM cell monolayers demonstrates that
lack of ORM blocks Ca2+ depletion -mediated reorganization of actin cytoskeleton and
microtubules. Changes in TER and inulin flux by LCM and Ca2+ restoration indicates that
barrier function is disrupted by Ca2+ depletion and restored by Ca2+ repletion in OclWT
cell monolayers. Absence of such changes in TER and inulin-flux in OclDM and Vec
monolayers, suggests that ORM is required for Ca2+ depletion mediated barrier
dysfunction in MDCK cell monolayers. Similar results in experiments using EGTA
mediated Ca2+ depletion model further confirmed the role of ORM in TJ and AJ
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disruption. Thus ORM plays a likely role in mediating TJ assembly/disassembly during
Ca2+ switch assay.
Cytochalasin D is a well-known disruptor of the actin-cytoskeleton and disruption
of actin cytoskeleton has been shown to disrupt epithelial TJ (91). Cytochalasin-D
mediated decrease in TER, increase in inulin-flux and redistribution of occludin in both
OclWT and OclDM cell monolayers suggests that ORM deletion does not affect
cytochalasin D-mediated TJ disruption and barrier dysfunction. Similarly, data show that
ORM deletion does not affect osmotic stress-mediated TJ disruption and barrier
dysfunction. Mechanical disruption by cytochalasin-D and osmotic stress might have
caused a drastic effect and irreversible damage to the TJ and hence the effect of ORM
deletion on barrier function was not evident in these cases.
Phosphorylation of ORM on T403/T404 and Y398/Y402 Determines the Dynamic
Properties of TJ
Previous studies in MDCK cells showed that expression of occludin with
T403/404A mutation attenuated TJ assembly, while that with T403/404D mutation
enhanced TJ assembly after Ca2+ switch (35). The results here show that T403/404A, but
not T403/404D, mutation confers resistance to Ca2+ depletion-mediated redistribution of
occludin and ZO-1 and barrier dysfunction, similar to ORM deletion mutation. This
suggested that T403 and T404 phosphorylation of occludin is required for mediating Ca2+
depletion-mediated TJ disruption. Also T403/404A, but not T403/404D mutation reduces
occludin mobility at the intercellular junctions similar to ORM deletion mutation. This
suggested that T403 and T404 phosphorylation contributes to mobility of occludin at the
intercellular junctions. In other words, the dynamic properties contributed by T403 and
T404 phosphorylation enables internalization of occudin during TJ disassembly while its
absence reduces mobile fraction of occludin and resists TJ disassembly by Ca2+
depletion.
Previous studies showed that expression of occludin with Y398/402A mutation
did not alter occludin localization at TJ during reassembly while that with Y398/402D
mutation delayed TJ assembly after Ca2+ switch. From the current data, resistance to
LCM-mediated barrier dysfunction and occludin/ZO-1 redistribution in the presence of
genistein confirmed that tyrosine phosphorylation is involved in Ca2+ depletion-mediated
TJ disruption. Y398/402A and Y398/402D mutations confer partial resistance to Ca2+
depletion-mediated redistribution of occludin/ZO-1 and TJ disruption, indicating that
both tyrosine phosphorylation and dephosphorylation may be involved in Ca2+ depletionmediated TJ disruption. The decrease in mobility due to both Y398/402A and
Y398/402D mutations suggested that tyrosine phosphorylation/dephosphorylation also
confer dynamics to TJ. These data together demonstrate that ORM confers dynamics to
TJ by a phosphorylation-dependent mechanism.
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Specific Aim 2: To Determine That ORM-mediated Protein Interactions Are
Involved in TJ Modulation
We believed that the translation of occludin phosphorylation signal into TJ
modulation, is mediated by proteins that interact with ORM. In order to further establish
the significance of ORM phosphorylation in TJ modulation, the strategy employed was
aimed to design a peptide that mimics ORM and investigate ORM-mediated protein
interactions.
ORP Enhances TJ Assembly and Barrier Function
Crystallography studies on occludin C-terminus determined that the distal part of
this domain (416-522) forms a coiled-coil structure but the proximal region from 383-415
does assume a secondary structure (31). Our data (unpublished) from studies on chicken
occludin C-terminus using hydrogen deuterium exchange coupled mass spectrometry
(HDE-MS) showed that there was significantly higher incorporation of deuterium in the
peptide corresponding to ORM sequence. On the other hand, the residues Y398, Y402,
T403, T404 and S408 are present as a cluster in a sequence, which is highly conserved
among species (34,92). From this information, it was evident that ORM is an active site
of phosphorylation that is readily available for ORM-mediated protein interactions.
To identify the proteins that interact with ORM, a peptide analogous to ORM
sequence (ORP) was designed with an N-terminus biotin tag and C-terminus TAT
domain. Examination of ORP permeability in Caco2-cells and mouse colonic loops,
showed increased uptake of ORP by the cells compared to that of the scrambled control.
The idea was to have ORP mimicking endogenous ORM sequence. Then the biological
effect of ORP was tested. Treatment with ORP enhanced TJ assembly and barrier
function during Ca2+ switch. Balda et al, showed that Occludin C-terminus governs
intracellular transport of occludin (85). This showed that the intracellular ORP might
have enabled occludin transport to the TJ and enhanced barrier function.
To further validate the biological effect of barrier function, a radiation model was
used. Caco-2 cells when exposed to radiation showed a decrease in TER and increase in
inulin-flux. However, when cells were pretreated with ORP, the radiation-induced
decrease in TER, increase in flux and redistribution of occludin and ZO-1 was
significantly attenuated. ORP was thought to attenuate radiation-induced barrier
dysfunction by enhancing ORM-mediated protein interactions involved in maintaining TJ
integrity. Thus far, the studies revealed that ORP has a potential to mimic endogenous
ORM and positively regulate TJ.
ORP Interacts with Proteins in a Phosphorylation-dependent Manner
In order to identify the proteins that interact with ORM, ORP was used as bait in
pull down assay coupled-mass spectrometry. ORM is differentially phosphorylated under
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different physiological conditions. Tyrosine phosphorylation of occludin is associated
with TJ disruption while threonine phosphorylation is involved in TJ assembly (36). To
identify proteins that interact with differentially phosphorylated ORM, ORP was prephosphorylated in vitro. Thus the method to phosphorylate in vitro was validated in our
previous studies. The same principle was employed to selectively phosphorylate ORP
either by incubation with c-Src, which is a tyrosine kinase, or CK2, which is a serine,
threonine kinase. Three forms of ORP were used as baits in the pull down assay: ORP in
its native form, tyrosine phosphorylated ORP (ORP-pY) and serine/threonine
phosphorylated ORP (ORP-pS/T).
Mass spectrometry of the pulled down samples was able to identify several
proteins in each group. The protein hits were further analyzed using Scaffold software
and statistically significant proteins were shortlisted. Some proteins were pulled down in
all three groups while some were unique to each group indicating the phosphorylation
dependent binding of proteins. I chose four proteins for further validation by immunoblot
analyses. PRDX1 and HSPD1 were pulled down in all the three groups while MAP7 and
PKP3 were pulled down exclusively by ORP-pY.
PRDX1 is a protein with dual roles since it acts as a peroxidase and as a
chaperone (93). PRDX1 is upregulated in human colorectal cancer and breast cancer
(94,95), both the cases where occludin downregulation was reported (69,96). Although
not much is known about role of PRDX1 in TJ, based on our pull down results it was
speculated that PRDX1 interaction with ORM could have a potential role in chaperoning
TJ proteins like occludin under physiological and pathophysiological conditions. PRDX1
however was pulled down with ORP irrespective of its phosphorylation status. Another
protein MAP7, which is a microtubule associated protein, was pulled down only by
tyrosine phosphorylated ORP. Since tyrosine phosphorylation is associated with TJ
disruption, an interaction between ORM and MAP7 indicated the existence of a potential
mechanism mediating occludin trafficking during stress. Hence we focused on
investigating the significance of the interaction between MAP7 and ORM.
MAP7 Interacts with Occludin by a Phosphorylation-dependent Mechanism
Because ORP is a synthetic peptide, it was essential to establish the interaction of
MAP7 with occludin in its native form. First a recombinant occludin C-terminus tagged
to GST was used to perform a pull down assay similar to that with ORP. Immunoblot
analysis for MAP7 and GST revealed that MAP7 bound specifically to GST-Ocl-C-pY.
This suggested that MAP7 directly interacts with occludin C-terminus, mediated by
tyrosine phosphorylation.
To further validate this interaction between full length occludin and MAP7, coimmunoprecipitation analyses was carried out in Caco-2 cells. Since MAP7 binds to
tyrosine-phosphorylated ORM, a stimulus that induced occludin phosphorylation was
needed. Osmotic stress and DSS are known to induce JNK and c-Src mediated
phosphorylation of occludin (83,84). Caco-2 cells were treated with either osmotic stress
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or DSS and MAP7 was immunoprecipitated from the native extracts. Immunoblot
analysis showed that although there was a basal amount of interaction between MAP7
and occludin, this was significantly enhanced by treatment with both osmotic stress and
DSS. This suggested that tyrosine phosphorylation of occludin enhances interaction with
MAP7 possibly mediated by the activation of JNK and c-Src.
Then I investigated the interaction between occludin and MAP7 in vivo.
Radiation causes TJ remodeling by inducing oxidative stress (97). Occludin undergoes
tyrosine phosphorylation during oxidative stress-induced disruption of TJ (52,53,98).
Hence a radiation model was used to induce tyrosine phosphorylation of occludin in vivo.
Mice were subjected to radiation and intestinal tissues were harvested 2 hr post radiation.
Colonic cryosections immunostained for occludin and MAP7 showed marked differences
between radiation treated and sham treated mice. Sites of occludin, MAP7 colocalization
were observed in the radiation exposed mouse colon but not in the sham treated control.
This suggested that MAP7 interacts with occludin which is tyrosine phosphorylated
possibly by the oxidative stress induced by ionizing radiation.
Ivanov et al., demonstrated that TJ disassembly is regulated by microtubules (99).
TJ disruption involves microtubule-mediated contraction of actomyosin ring as well as
microtubule-mediated internalization of TJ proteins. It was shown that Kinesin-1 is a
motor protein that drives dynamic reorganization of microtubules and trafficking of TJ
proteins. Kinesin-1 colocalizes with occludin at TJ as well as with occludin that was
internalized by Ca2+ depletion (99). MAP7 is an epithelial specific microtubule associated
protein and an essential cofactor for kinesin-1 (100,101). These observations suggested
that MAP7 is the potential regulatory protein that in association with Kinesin-1 drives the
trafficking of tyrosine-phosphorylated occludin during TJ disruption (Figure 4-1).
Summary
In conclusion, this series of studies determined the functional significance of
ORM in TJ regulation. These studies identified that ORM plays an important role in
mediating TJ assembly/disassembly during Ca2+ switch assay. The correlation between
occludin phosphorylation and TJ modulation is further supported by the observation that
ORM-mediated phosphorylation confers dynamic properties to TJ. They also shed light
on the potential role of ORM in regulating pore pathway flux, which is mediated by poreforming claudins. MAP7, for the first time, has been identified as an ORM-interacting
partner that mediates trafficking of occludin during TJ disruption. ORM is a highly
dynamic site that recruits signaling molecules to modulate TJ, a mechanism most likely
exploited during pathogenesis of several diseases associated with barrier dysfunction.
The data here unravels novel mechanisms and associated proteins involved in TJ
regulation that might prove to be potential therapeutic targets for TJ modulation.
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Figure 4-1.

MAP7 Mediates Trafficking of Occludin During TJ Regulation.

ORM is a site for phosphorylation dependent regulation of occludin. Tyrosine
phosphorylation of occludin induces interaction with MAP7, which in association with
kinesin-1 mediates dynamic regulation of occludin. Under pathological conditions such
as radiation-induced oxidative stress, tyrosine kinase like c-Src is activated. Sustained
phosphorylation of tyrosine residues in ORM enhances interaction with MAP7, which in
association with kinesin-1and microtubule mediates internalization of occludin leading to
TJ modulation.
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